<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:13e79982-bfab-410b-923c-3919d2407af3,g:0bd176bf-2959-47c0-8d14-835dd09c3ee5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ivericbio.com/role/Cover" xlink:type="simple" xlink:href="isee-20211231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:href="isee-20211231.xsd#isee_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8cb1fb39-92b5-400a-af42-a041d0922116" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_DocumentType_8cb1fb39-92b5-400a-af42-a041d0922116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_0fe1e669-7cb6-4235-8838-3e8bb09363e8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_DocumentAnnualReport_0fe1e669-7cb6-4235-8838-3e8bb09363e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_23b6a8bb-cf72-4a06-90e2-b1d12d9d0e24" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_DocumentPeriodEndDate_23b6a8bb-cf72-4a06-90e2-b1d12d9d0e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_59e97231-cde3-4d18-8918-404a79cb7e7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_CurrentFiscalYearEndDate_59e97231-cde3-4d18-8918-404a79cb7e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_0783216a-da5b-43c0-8e8b-37e26ec6bdc5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_DocumentTransitionReport_0783216a-da5b-43c0-8e8b-37e26ec6bdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c8247181-41d1-4619-82a9-da88e8c6d500" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityFileNumber_c8247181-41d1-4619-82a9-da88e8c6d500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9afe586d-2a6b-48ab-a5d8-51730095eb85" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityRegistrantName_9afe586d-2a6b-48ab-a5d8-51730095eb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bb0612c9-6e1e-45e1-8b16-2a647cd49e6b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bb0612c9-6e1e-45e1-8b16-2a647cd49e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8e596158-2406-4dce-83ba-369aa752a5c0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityTaxIdentificationNumber_8e596158-2406-4dce-83ba-369aa752a5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_44655452-3f4f-46fb-94f5-45b8e03202e3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityAddressAddressLine1_44655452-3f4f-46fb-94f5-45b8e03202e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ddaecad4-4b2c-45bc-a0e1-7f89178821d8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityAddressCityOrTown_ddaecad4-4b2c-45bc-a0e1-7f89178821d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_96474ea3-88b0-4443-8901-4226e1e9ceab" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityAddressStateOrProvince_96474ea3-88b0-4443-8901-4226e1e9ceab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6c1dac16-98e5-45e9-b187-804673852599" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityAddressPostalZipCode_6c1dac16-98e5-45e9-b187-804673852599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4a0318ae-ccd7-4fb8-9857-92c3d5f0bbd5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_CityAreaCode_4a0318ae-ccd7-4fb8-9857-92c3d5f0bbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6a4bd039-a707-451e-84ee-650be7adaf89" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_LocalPhoneNumber_6a4bd039-a707-451e-84ee-650be7adaf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_736d2cdc-cc4b-47ef-a410-c65cb5b4bc26" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_Security12bTitle_736d2cdc-cc4b-47ef-a410-c65cb5b4bc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_0555bf83-e80b-4c1a-a4f9-7afc94294ede" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_TradingSymbol_0555bf83-e80b-4c1a-a4f9-7afc94294ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_772a8cae-327b-4731-af98-6b03d5d3c788" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_SecurityExchangeName_772a8cae-327b-4731-af98-6b03d5d3c788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a34d078f-a099-4829-9743-274e1b574a5f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a34d078f-a099-4829-9743-274e1b574a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_af0b85b5-de1b-44ba-922c-443e2ae6450f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityVoluntaryFilers_af0b85b5-de1b-44ba-922c-443e2ae6450f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_161d74a0-7d8c-44d1-954e-f5d79be45c38" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityCurrentReportingStatus_161d74a0-7d8c-44d1-954e-f5d79be45c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_0b9d93c1-b630-4ab1-a9d7-2c06ccf93222" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityInteractiveDataCurrent_0b9d93c1-b630-4ab1-a9d7-2c06ccf93222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_28cd3fe5-2292-469f-8168-03e37c86745e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityFilerCategory_28cd3fe5-2292-469f-8168-03e37c86745e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c4535a10-5a80-4ede-9aa8-11bbe3ceac5d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntitySmallBusiness_c4535a10-5a80-4ede-9aa8-11bbe3ceac5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_50bf03d3-88ed-47ad-8f5e-4bcaf1176e5c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityEmergingGrowthCompany_50bf03d3-88ed-47ad-8f5e-4bcaf1176e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_a5643e63-9282-441e-95ab-02f2cd468232" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_IcfrAuditorAttestationFlag_a5643e63-9282-441e-95ab-02f2cd468232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b9861911-134f-490f-b8d9-631552b625c2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityShellCompany_b9861911-134f-490f-b8d9-631552b625c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_cbc27c30-a330-4a88-ba50-bccab81d1ac4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityPublicFloat_cbc27c30-a330-4a88-ba50-bccab81d1ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_bfa611b8-832f-4f23-9dca-b8f2d2735805" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_bfa611b8-832f-4f23-9dca-b8f2d2735805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_a1c2b2f1-6c08-40a1-ac9b-8d3fc605847a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_a1c2b2f1-6c08-40a1-ac9b-8d3fc605847a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_23d9b4b8-b8a2-456f-a40a-9c380094ea36" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_EntityCentralIndexKey_23d9b4b8-b8a2-456f-a40a-9c380094ea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d96bdd1b-0899-45ad-ab2a-640bbb31543f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_AmendmentFlag_d96bdd1b-0899-45ad-ab2a-640bbb31543f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5c27255c-a9e9-4e9c-b8d3-4a554752f22f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_DocumentFiscalYearFocus_5c27255c-a9e9-4e9c-b8d3-4a554752f22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6a89ffb5-2fb8-4b5b-b516-ee6b5c003d69" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_DocumentAndEntityInformationAbstract_eb402ebe-6573-4831-8905-d308ecab8911" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6a89ffb5-2fb8-4b5b-b516-ee6b5c003d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/AuditInformation" xlink:type="simple" xlink:href="isee-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_isee_AuditorInformationAbstract_4ff9bca7-1148-47a9-ad8f-dac45a9500ab" xlink:href="isee-20211231.xsd#isee_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_0869b7ac-79af-4a24-96cb-d66761f8afc6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_AuditorInformationAbstract_4ff9bca7-1148-47a9-ad8f-dac45a9500ab" xlink:to="loc_dei_AuditorFirmId_0869b7ac-79af-4a24-96cb-d66761f8afc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_c3c7881f-fe21-4249-adec-6178ba2b90f7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_AuditorInformationAbstract_4ff9bca7-1148-47a9-ad8f-dac45a9500ab" xlink:to="loc_dei_AuditorName_c3c7881f-fe21-4249-adec-6178ba2b90f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_a8b2c529-8e62-4561-a1ff-095fe5e95b3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_AuditorInformationAbstract_4ff9bca7-1148-47a9-ad8f-dac45a9500ab" xlink:to="loc_dei_AuditorLocation_a8b2c529-8e62-4561-a1ff-095fe5e95b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="isee-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8c92ac06-e841-4643-926b-4defd7b81251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_7f9cdec0-1b3c-466b-a341-7c1cee31eef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8c92ac06-e841-4643-926b-4defd7b81251" xlink:to="loc_us-gaap_AssetsAbstract_7f9cdec0-1b3c-466b-a341-7c1cee31eef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_223f4067-337f-412b-94d3-ac0ebfae1b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f9cdec0-1b3c-466b-a341-7c1cee31eef7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_223f4067-337f-412b-94d3-ac0ebfae1b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_af64358c-7b29-4404-af14-b752bcc791f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_223f4067-337f-412b-94d3-ac0ebfae1b58" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_af64358c-7b29-4404-af14-b752bcc791f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_be58b41c-ca97-43bd-938f-d6476339bec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_223f4067-337f-412b-94d3-ac0ebfae1b58" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_be58b41c-ca97-43bd-938f-d6476339bec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_24e3f64b-d294-474a-a0e2-600371653bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_223f4067-337f-412b-94d3-ac0ebfae1b58" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_24e3f64b-d294-474a-a0e2-600371653bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_7f16a27e-e1e4-4b01-bbae-b5f39b314d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_223f4067-337f-412b-94d3-ac0ebfae1b58" xlink:to="loc_us-gaap_IncomeTaxesReceivable_7f16a27e-e1e4-4b01-bbae-b5f39b314d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a4efdcd1-1b0f-4b34-bce6-1b2675536354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_223f4067-337f-412b-94d3-ac0ebfae1b58" xlink:to="loc_us-gaap_AssetsCurrent_a4efdcd1-1b0f-4b34-bce6-1b2675536354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3073f2f6-d57d-4a8d-ae97-50e07b669d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f9cdec0-1b3c-466b-a341-7c1cee31eef7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3073f2f6-d57d-4a8d-ae97-50e07b669d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a001791b-a327-4eeb-ac98-ba30c20b2596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f9cdec0-1b3c-466b-a341-7c1cee31eef7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a001791b-a327-4eeb-ac98-ba30c20b2596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7edceec6-7fe1-4cb4-9e75-1eaf652ec6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f9cdec0-1b3c-466b-a341-7c1cee31eef7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7edceec6-7fe1-4cb4-9e75-1eaf652ec6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9209c0f1-095f-455e-a22e-4c45b792a565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7f9cdec0-1b3c-466b-a341-7c1cee31eef7" xlink:to="loc_us-gaap_Assets_9209c0f1-095f-455e-a22e-4c45b792a565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f13830e-2daa-4c8a-a913-128f690997b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8c92ac06-e841-4643-926b-4defd7b81251" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f13830e-2daa-4c8a-a913-128f690997b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6452954d-6b64-4cdc-bea5-c7dbb28f226a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f13830e-2daa-4c8a-a913-128f690997b2" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6452954d-6b64-4cdc-bea5-c7dbb28f226a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AccruedResearchAndDevelopment_d50497ea-d9f9-4192-a1e9-21c4fe23036a" xlink:href="isee-20211231.xsd#isee_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6452954d-6b64-4cdc-bea5-c7dbb28f226a" xlink:to="loc_isee_AccruedResearchAndDevelopment_d50497ea-d9f9-4192-a1e9-21c4fe23036a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_dcf2dfe5-8b88-49d0-836b-257a2a2053ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6452954d-6b64-4cdc-bea5-c7dbb28f226a" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_dcf2dfe5-8b88-49d0-836b-257a2a2053ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_36c5a88d-fda6-4d71-b731-c4e94c225b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6452954d-6b64-4cdc-bea5-c7dbb28f226a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_36c5a88d-fda6-4d71-b731-c4e94c225b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_195456fa-7bc9-4ff5-b7f5-3a2b8ca7ebe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6452954d-6b64-4cdc-bea5-c7dbb28f226a" xlink:to="loc_us-gaap_LiabilitiesCurrent_195456fa-7bc9-4ff5-b7f5-3a2b8ca7ebe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fcaba6ce-2345-43a0-9439-a8e130eeee61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f13830e-2daa-4c8a-a913-128f690997b2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fcaba6ce-2345-43a0-9439-a8e130eeee61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4757bc77-1382-4b15-a4a1-16a1c93e86f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f13830e-2daa-4c8a-a913-128f690997b2" xlink:to="loc_us-gaap_Liabilities_4757bc77-1382-4b15-a4a1-16a1c93e86f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_68b78797-9a89-4a51-8aaa-ad315670b975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f13830e-2daa-4c8a-a913-128f690997b2" xlink:to="loc_us-gaap_StockholdersEquityAbstract_68b78797-9a89-4a51-8aaa-ad315670b975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c24b6050-c8e9-4507-88a6-606088d6d33b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_68b78797-9a89-4a51-8aaa-ad315670b975" xlink:to="loc_us-gaap_PreferredStockValue_c24b6050-c8e9-4507-88a6-606088d6d33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_44d10056-b5dd-431b-9d4a-97cd228b7c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_68b78797-9a89-4a51-8aaa-ad315670b975" xlink:to="loc_us-gaap_CommonStockValue_44d10056-b5dd-431b-9d4a-97cd228b7c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5bc83316-45ec-46c2-b9ba-6200f2a505e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_68b78797-9a89-4a51-8aaa-ad315670b975" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5bc83316-45ec-46c2-b9ba-6200f2a505e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c8e986c-a395-474a-ae0f-1bf2afc02477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_68b78797-9a89-4a51-8aaa-ad315670b975" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c8e986c-a395-474a-ae0f-1bf2afc02477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5c76479a-74aa-459e-9a42-bb077ee931f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_68b78797-9a89-4a51-8aaa-ad315670b975" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5c76479a-74aa-459e-9a42-bb077ee931f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_726d3db6-307a-40a2-a6e9-57318ba74a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_68b78797-9a89-4a51-8aaa-ad315670b975" xlink:to="loc_us-gaap_StockholdersEquity_726d3db6-307a-40a2-a6e9-57318ba74a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8fa12235-de63-46c0-b45a-b1fc7b0beaea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f13830e-2daa-4c8a-a913-128f690997b2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8fa12235-de63-46c0-b45a-b1fc7b0beaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="isee-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_aa914c94-d2d9-47ec-a8e6-5119b8df164c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6f2f918e-d504-44b8-b97b-0ae5d18d90b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa914c94-d2d9-47ec-a8e6-5119b8df164c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6f2f918e-d504-44b8-b97b-0ae5d18d90b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_bc8f4398-1eb8-49f8-8ceb-86986c301a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa914c94-d2d9-47ec-a8e6-5119b8df164c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_bc8f4398-1eb8-49f8-8ceb-86986c301a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_929cf92d-6f45-446c-b2ab-7f25661ee89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa914c94-d2d9-47ec-a8e6-5119b8df164c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_929cf92d-6f45-446c-b2ab-7f25661ee89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ee456419-25c6-47b1-9b39-7365fc330e98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa914c94-d2d9-47ec-a8e6-5119b8df164c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ee456419-25c6-47b1-9b39-7365fc330e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d4d75611-df6c-447a-b970-358fda4630ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa914c94-d2d9-47ec-a8e6-5119b8df164c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d4d75611-df6c-447a-b970-358fda4630ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3f89c3fe-7d9f-42c6-8ff7-8f8d2dbd4889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa914c94-d2d9-47ec-a8e6-5119b8df164c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3f89c3fe-7d9f-42c6-8ff7-8f8d2dbd4889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_cd4f488f-0909-4d8b-af66-88b7a7eaa158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa914c94-d2d9-47ec-a8e6-5119b8df164c" xlink:to="loc_us-gaap_CommonStockSharesIssued_cd4f488f-0909-4d8b-af66-88b7a7eaa158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_28a02e67-b64c-4a39-bafa-a7458dcd28d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_aa914c94-d2d9-47ec-a8e6-5119b8df164c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_28a02e67-b64c-4a39-bafa-a7458dcd28d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="isee-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_19608d86-f686-45b7-95d4-536f63d62005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:to="loc_us-gaap_OperatingExpensesAbstract_19608d86-f686-45b7-95d4-536f63d62005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ca0aeb26-b96f-4652-b6b0-110d5d12e7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_19608d86-f686-45b7-95d4-536f63d62005" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ca0aeb26-b96f-4652-b6b0-110d5d12e7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_32fdd8c5-eca9-4a58-b5c5-3a26d95ca086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_19608d86-f686-45b7-95d4-536f63d62005" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_32fdd8c5-eca9-4a58-b5c5-3a26d95ca086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b3648c1e-7c09-47e1-ae7e-13b97d92ba6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_19608d86-f686-45b7-95d4-536f63d62005" xlink:to="loc_us-gaap_OperatingExpenses_b3648c1e-7c09-47e1-ae7e-13b97d92ba6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2f93a6a6-bffe-4b23-a2de-1015d305496f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:to="loc_us-gaap_OperatingIncomeLoss_2f93a6a6-bffe-4b23-a2de-1015d305496f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_d44f9a17-1069-4951-bc64-f55c7a8d998b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_d44f9a17-1069-4951-bc64-f55c7a8d998b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5216805c-3a68-42fc-9fa1-98dc646b3dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5216805c-3a68-42fc-9fa1-98dc646b3dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_21469a83-8147-48c2-b4f8-ea467ccb3c70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_21469a83-8147-48c2-b4f8-ea467ccb3c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_518d8b0a-df61-4989-b482-a87dedc8c5be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_518d8b0a-df61-4989-b482-a87dedc8c5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01931b6c-c7f1-497a-a4d3-166f275e8006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:to="loc_us-gaap_NetIncomeLoss_01931b6c-c7f1-497a-a4d3-166f275e8006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a44b5c69-2451-4e54-a650-15876f7f08c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a44b5c69-2451-4e54-a650-15876f7f08c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_242e75b0-334a-4bdf-920a-be98682a984c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a44b5c69-2451-4e54-a650-15876f7f08c4" xlink:to="loc_us-gaap_EarningsPerShareBasic_242e75b0-334a-4bdf-920a-be98682a984c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8c00282b-3fbb-45fd-9eba-40ba6351b8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a44b5c69-2451-4e54-a650-15876f7f08c4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8c00282b-3fbb-45fd-9eba-40ba6351b8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_068a5715-7290-4269-a65d-a3d6c95f05a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_519727ff-cd8c-44c8-ba0d-32375f0669c3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_068a5715-7290-4269-a65d-a3d6c95f05a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7fa9dd0-c824-4fe7-a09e-f8da43b7ba47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_068a5715-7290-4269-a65d-a3d6c95f05a2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7fa9dd0-c824-4fe7-a09e-f8da43b7ba47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_75d962fb-5c23-446d-bf45-5b6f74f2a8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_068a5715-7290-4269-a65d-a3d6c95f05a2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_75d962fb-5c23-446d-bf45-5b6f74f2a8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="isee-20211231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6988a0f3-34fe-4ec1-b5ae-bdb7b98e6045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5827da43-75e7-412d-9d6d-1ecac05ac06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6988a0f3-34fe-4ec1-b5ae-bdb7b98e6045" xlink:to="loc_us-gaap_NetIncomeLoss_5827da43-75e7-412d-9d6d-1ecac05ac06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_f731ccfa-9922-42aa-b8ea-38e7d1787469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6988a0f3-34fe-4ec1-b5ae-bdb7b98e6045" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_f731ccfa-9922-42aa-b8ea-38e7d1787469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_69b0efad-debb-4c7d-9602-f4c61dbac60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_f731ccfa-9922-42aa-b8ea-38e7d1787469" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_69b0efad-debb-4c7d-9602-f4c61dbac60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e28f2ab1-1d65-4122-9e9b-8c10e9ce3876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_f731ccfa-9922-42aa-b8ea-38e7d1787469" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e28f2ab1-1d65-4122-9e9b-8c10e9ce3876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2983b298-ea52-41dc-84fb-85d19a724fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6988a0f3-34fe-4ec1-b5ae-bdb7b98e6045" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2983b298-ea52-41dc-84fb-85d19a724fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="isee-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0e57f4a0-e863-43f7-b42d-b633074f9a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_28c795b7-3a85-43c5-8758-ffcd6aa3530e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0e57f4a0-e863-43f7-b42d-b633074f9a93" xlink:to="loc_us-gaap_StatementTable_28c795b7-3a85-43c5-8758-ffcd6aa3530e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4948f47a-441e-48c2-aeda-a19b46da8e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_28c795b7-3a85-43c5-8758-ffcd6aa3530e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4948f47a-441e-48c2-aeda-a19b46da8e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_53a1ce65-af86-4d65-b1e9-6f840f7469cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4948f47a-441e-48c2-aeda-a19b46da8e09" xlink:to="loc_us-gaap_EquityComponentDomain_53a1ce65-af86-4d65-b1e9-6f840f7469cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_JuniorSeriesAConvertiblePreferredStockMember_167c5a0b-b685-415b-b7a3-2ea1e8ae759c" xlink:href="isee-20211231.xsd#isee_JuniorSeriesAConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53a1ce65-af86-4d65-b1e9-6f840f7469cf" xlink:to="loc_isee_JuniorSeriesAConvertiblePreferredStockMember_167c5a0b-b685-415b-b7a3-2ea1e8ae759c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9813c7a0-6d0b-4459-b5e5-cc7cca78186f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53a1ce65-af86-4d65-b1e9-6f840f7469cf" xlink:to="loc_us-gaap_CommonStockMember_9813c7a0-6d0b-4459-b5e5-cc7cca78186f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8b051c34-fcb3-4c60-ae34-10b23624920a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53a1ce65-af86-4d65-b1e9-6f840f7469cf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8b051c34-fcb3-4c60-ae34-10b23624920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_31837188-1e83-468a-80d6-3ada9ad1ee4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53a1ce65-af86-4d65-b1e9-6f840f7469cf" xlink:to="loc_us-gaap_RetainedEarningsMember_31837188-1e83-468a-80d6-3ada9ad1ee4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c8b30415-06f9-42d8-8a5a-2c5f76a14207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53a1ce65-af86-4d65-b1e9-6f840f7469cf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c8b30415-06f9-42d8-8a5a-2c5f76a14207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4dfb1722-dd8c-40c0-b2a7-f39e25bd7b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_28c795b7-3a85-43c5-8758-ffcd6aa3530e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4dfb1722-dd8c-40c0-b2a7-f39e25bd7b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b95ef534-8e62-4f16-a1fa-b6c32d5ada1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4dfb1722-dd8c-40c0-b2a7-f39e25bd7b66" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b95ef534-8e62-4f16-a1fa-b6c32d5ada1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UnderwrittenOfferingMember_d2617780-6201-4784-b0f1-c263842c4d25" xlink:href="isee-20211231.xsd#isee_UnderwrittenOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b95ef534-8e62-4f16-a1fa-b6c32d5ada1d" xlink:to="loc_isee_UnderwrittenOfferingMember_d2617780-6201-4784-b0f1-c263842c4d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_89686b0d-0ab4-4cbb-a91d-cde9e7cf0ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b95ef534-8e62-4f16-a1fa-b6c32d5ada1d" xlink:to="loc_us-gaap_PrivatePlacementMember_89686b0d-0ab4-4cbb-a91d-cde9e7cf0ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ee5fa64d-2c20-4844-b6fa-4cc3238f100b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_28c795b7-3a85-43c5-8758-ffcd6aa3530e" xlink:to="loc_us-gaap_StatementLineItems_ee5fa64d-2c20-4844-b6fa-4cc3238f100b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ee5fa64d-2c20-4844-b6fa-4cc3238f100b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ec381329-952a-418a-ad62-7ba59d91d900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_SharesIssued_ec381329-952a-418a-ad62-7ba59d91d900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a1dfe244-b6c7-4790-99be-5cdae41a0d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockholdersEquity_a1dfe244-b6c7-4790-99be-5cdae41a0d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0a9bce9c-be29-4a26-b9d5-7a6cd8ad7bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0a9bce9c-be29-4a26-b9d5-7a6cd8ad7bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_9f2c067f-f1d3-4c2f-9aae-f2923fc3f143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_9f2c067f-f1d3-4c2f-9aae-f2923fc3f143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_9869c42b-68f0-4b6a-9730-70d20a372e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_9869c42b-68f0-4b6a-9730-70d20a372e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4d9a3db6-6bd2-4953-b1e4-773e99e7a037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4d9a3db6-6bd2-4953-b1e4-773e99e7a037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_b0adcf4b-f503-4b07-8c8f-61a09a033fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_b0adcf4b-f503-4b07-8c8f-61a09a033fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_ee73a692-ce43-4b38-a2d3-ffa5dcd1bc96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_ee73a692-ce43-4b38-a2d3-ffa5dcd1bc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_4ce76a53-7fdc-434c-924f-1056e34ed223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_4ce76a53-7fdc-434c-924f-1056e34ed223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_c2eab24d-8bb9-4cc4-92e5-f80e981afbae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_c2eab24d-8bb9-4cc4-92e5-f80e981afbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_87b95df2-4c15-4039-b416-b502c8c7e458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_87b95df2-4c15-4039-b416-b502c8c7e458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c58e2762-52f1-43d3-aaad-b72a285edd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_NetIncomeLoss_c58e2762-52f1-43d3-aaad-b72a285edd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_658d26b7-3236-404d-afed-1f27976ea98d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_658d26b7-3236-404d-afed-1f27976ea98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6a8c164e-2788-4139-912d-958f44e98cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_SharesIssued_6a8c164e-2788-4139-912d-958f44e98cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_04397cd0-bf18-43d6-a528-883df830ea3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b98ae6db-81b0-465b-873a-7f8d15d1e0ce" xlink:to="loc_us-gaap_StockholdersEquity_04397cd0-bf18-43d6-a528-883df830ea3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="isee-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_264140d2-9413-4fe6-a8ef-ea97b9f2404c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0b7a80f4-a7ea-47ed-99dc-00200910d17b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_264140d2-9413-4fe6-a8ef-ea97b9f2404c" xlink:to="loc_us-gaap_StatementTable_0b7a80f4-a7ea-47ed-99dc-00200910d17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_cd51214a-6f92-43f3-9498-c4ed1485046e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0b7a80f4-a7ea-47ed-99dc-00200910d17b" xlink:to="loc_us-gaap_AssetAcquisitionAxis_cd51214a-6f92-43f3-9498-c4ed1485046e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_14765d77-c564-4ccc-9e89-1854cdc073ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_cd51214a-6f92-43f3-9498-c4ed1485046e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_14765d77-c564-4ccc-9e89-1854cdc073ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_Inception4Member_cc861c10-4344-42cc-ae50-f0c2284de7cf" xlink:href="isee-20211231.xsd#isee_Inception4Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_14765d77-c564-4ccc-9e89-1854cdc073ee" xlink:to="loc_isee_Inception4Member_cc861c10-4344-42cc-ae50-f0c2284de7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_0161ba5f-b8ff-4e24-8391-587801ff82d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0b7a80f4-a7ea-47ed-99dc-00200910d17b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_0161ba5f-b8ff-4e24-8391-587801ff82d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d600cba3-aefc-4592-8bdd-3e707863e703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_0161ba5f-b8ff-4e24-8391-587801ff82d9" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d600cba3-aefc-4592-8bdd-3e707863e703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PublicStockOfferingMember_9720ba1d-4ede-46e1-b368-590c7c243fee" xlink:href="isee-20211231.xsd#isee_PublicStockOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d600cba3-aefc-4592-8bdd-3e707863e703" xlink:to="loc_isee_PublicStockOfferingMember_9720ba1d-4ede-46e1-b368-590c7c243fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_02f9364c-95db-441c-a087-f7426175da86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d600cba3-aefc-4592-8bdd-3e707863e703" xlink:to="loc_us-gaap_PrivatePlacementMember_02f9364c-95db-441c-a087-f7426175da86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_567f0b5a-32e5-4df1-9c30-9a281eebaee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0b7a80f4-a7ea-47ed-99dc-00200910d17b" xlink:to="loc_us-gaap_StatementLineItems_567f0b5a-32e5-4df1-9c30-9a281eebaee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_bcddb342-48f0-41f4-a985-55328c8efb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_567f0b5a-32e5-4df1-9c30-9a281eebaee4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_bcddb342-48f0-41f4-a985-55328c8efb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9629fc6a-92ac-4abe-ba47-1f7b84a89ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_bcddb342-48f0-41f4-a985-55328c8efb8e" xlink:to="loc_us-gaap_NetIncomeLoss_9629fc6a-92ac-4abe-ba47-1f7b84a89ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce4b0b2b-c42a-4f2a-b3c0-8361cd231978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_bcddb342-48f0-41f4-a985-55328c8efb8e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce4b0b2b-c42a-4f2a-b3c0-8361cd231978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b59bdf05-5aff-42da-a27b-76a67461e0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce4b0b2b-c42a-4f2a-b3c0-8361cd231978" xlink:to="loc_us-gaap_Depreciation_b59bdf05-5aff-42da-a27b-76a67461e0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_65d1d347-c5d6-4ae4-8405-f08dcec4ae7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce4b0b2b-c42a-4f2a-b3c0-8361cd231978" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_65d1d347-c5d6-4ae4-8405-f08dcec4ae7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f3800ea0-3077-4a7b-a71e-c7dc98cfafe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce4b0b2b-c42a-4f2a-b3c0-8361cd231978" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f3800ea0-3077-4a7b-a71e-c7dc98cfafe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b50feef6-1a57-4865-b615-fbe1f847d7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce4b0b2b-c42a-4f2a-b3c0-8361cd231978" xlink:to="loc_us-gaap_ShareBasedCompensation_b50feef6-1a57-4865-b615-fbe1f847d7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_IncreaseDecreaseInWorkingCapital_ae61a02a-2fdd-4e7a-8e23-9d819430e85f" xlink:href="isee-20211231.xsd#isee_IncreaseDecreaseInWorkingCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce4b0b2b-c42a-4f2a-b3c0-8361cd231978" xlink:to="loc_isee_IncreaseDecreaseInWorkingCapital_ae61a02a-2fdd-4e7a-8e23-9d819430e85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedPaymentArrangementNoncashExpenseInConnectionWithLicenseAcquisition_53a7c036-a8f0-4ba6-904c-6a044a18608d" xlink:href="isee-20211231.xsd#isee_ShareBasedPaymentArrangementNoncashExpenseInConnectionWithLicenseAcquisition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce4b0b2b-c42a-4f2a-b3c0-8361cd231978" xlink:to="loc_isee_ShareBasedPaymentArrangementNoncashExpenseInConnectionWithLicenseAcquisition_53a7c036-a8f0-4ba6-904c-6a044a18608d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8907241e-a012-410d-b6d2-1b2fb274f0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce4b0b2b-c42a-4f2a-b3c0-8361cd231978" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8907241e-a012-410d-b6d2-1b2fb274f0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_3716f670-c103-421b-a58e-0ccc981113d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8907241e-a012-410d-b6d2-1b2fb274f0cc" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_3716f670-c103-421b-a58e-0ccc981113d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_67c2f320-a6f3-4772-80e0-2059bf4b4064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8907241e-a012-410d-b6d2-1b2fb274f0cc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_67c2f320-a6f3-4772-80e0-2059bf4b4064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets_514a09a7-149e-4d54-84a8-df269cf27a50" xlink:href="isee-20211231.xsd#isee_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8907241e-a012-410d-b6d2-1b2fb274f0cc" xlink:to="loc_isee_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets_514a09a7-149e-4d54-84a8-df269cf27a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_d0f96145-17a1-446f-b32f-3e2a6839e9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8907241e-a012-410d-b6d2-1b2fb274f0cc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_d0f96145-17a1-446f-b32f-3e2a6839e9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_IncreaseDecreaseInAccruedResearchAndDevelopment_0518c2c3-91c8-4f4a-a434-706f7fdfde97" xlink:href="isee-20211231.xsd#isee_IncreaseDecreaseInAccruedResearchAndDevelopment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8907241e-a012-410d-b6d2-1b2fb274f0cc" xlink:to="loc_isee_IncreaseDecreaseInAccruedResearchAndDevelopment_0518c2c3-91c8-4f4a-a434-706f7fdfde97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b12c385e-f4fc-4be2-8fc0-420d8eeb16e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8907241e-a012-410d-b6d2-1b2fb274f0cc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b12c385e-f4fc-4be2-8fc0-420d8eeb16e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1e4f910b-2f26-4c26-9e2c-8d145a2c0473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_bcddb342-48f0-41f4-a985-55328c8efb8e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1e4f910b-2f26-4c26-9e2c-8d145a2c0473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_6170b92c-f4c9-4faa-8f76-742c8217e557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_567f0b5a-32e5-4df1-9c30-9a281eebaee4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_6170b92c-f4c9-4faa-8f76-742c8217e557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_62bd5325-6ca6-4c1a-8ae6-42706680f4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_6170b92c-f4c9-4faa-8f76-742c8217e557" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_62bd5325-6ca6-4c1a-8ae6-42706680f4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_e1b300b1-2094-4896-9ce3-3f7d7be4e21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_6170b92c-f4c9-4faa-8f76-742c8217e557" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_e1b300b1-2094-4896-9ce3-3f7d7be4e21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3e63620a-4447-4d5c-be7f-6fe3e1cb2460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_6170b92c-f4c9-4faa-8f76-742c8217e557" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3e63620a-4447-4d5c-be7f-6fe3e1cb2460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_5add3597-4f41-4990-b3f7-d25024cb4fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_6170b92c-f4c9-4faa-8f76-742c8217e557" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_5add3597-4f41-4990-b3f7-d25024cb4fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e15ada01-8695-4f4b-aeb7-3086786e82a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_6170b92c-f4c9-4faa-8f76-742c8217e557" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e15ada01-8695-4f4b-aeb7-3086786e82a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_84649457-31e2-471f-8b31-c0082a8ca7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_567f0b5a-32e5-4df1-9c30-9a281eebaee4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_84649457-31e2-471f-8b31-c0082a8ca7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_2398438e-ecff-4afb-a909-b47000ba23b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_84649457-31e2-471f-8b31-c0082a8ca7aa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_2398438e-ecff-4afb-a909-b47000ba23b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ProceedsFromStockOptionsAndWarrantsExercised_6dd8ab8b-e5ed-4405-8233-0c84bcfa6e10" xlink:href="isee-20211231.xsd#isee_ProceedsFromStockOptionsAndWarrantsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_84649457-31e2-471f-8b31-c0082a8ca7aa" xlink:to="loc_isee_ProceedsFromStockOptionsAndWarrantsExercised_6dd8ab8b-e5ed-4405-8233-0c84bcfa6e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e9fb5ab-4f08-425b-b74b-07c860136c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_84649457-31e2-471f-8b31-c0082a8ca7aa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e9fb5ab-4f08-425b-b74b-07c860136c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_baa26bed-38b9-4fcc-84ce-834621616c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_567f0b5a-32e5-4df1-9c30-9a281eebaee4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_baa26bed-38b9-4fcc-84ce-834621616c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_8a222677-3ca7-410d-a488-b748a8595e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_567f0b5a-32e5-4df1-9c30-9a281eebaee4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_8a222677-3ca7-410d-a488-b748a8595e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7a4ece9-15bb-428a-b1c8-6867a0a37af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_8a222677-3ca7-410d-a488-b748a8595e8f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7a4ece9-15bb-428a-b1c8-6867a0a37af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6fc62545-ca46-430c-8cc3-a2a67d1d803c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_8a222677-3ca7-410d-a488-b748a8595e8f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6fc62545-ca46-430c-8cc3-a2a67d1d803c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SupplementalDisclosureOfCashPaidAbstract_c9214186-11ac-4115-8bdc-f454d3aec39d" xlink:href="isee-20211231.xsd#isee_SupplementalDisclosureOfCashPaidAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_567f0b5a-32e5-4df1-9c30-9a281eebaee4" xlink:to="loc_isee_SupplementalDisclosureOfCashPaidAbstract_c9214186-11ac-4115-8bdc-f454d3aec39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_dc7ee453-f3cb-4e21-af64-4b85b4c8c9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_SupplementalDisclosureOfCashPaidAbstract_c9214186-11ac-4115-8bdc-f454d3aec39d" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_dc7ee453-f3cb-4e21-af64-4b85b4c8c9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cacec00e-99f0-4372-ad4a-fac3ba68c03d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_567f0b5a-32e5-4df1-9c30-9a281eebaee4" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cacec00e-99f0-4372-ad4a-fac3ba68c03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6a460ef1-1bed-4f3d-9d9b-5b1d150c01ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cacec00e-99f0-4372-ad4a-fac3ba68c03d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6a460ef1-1bed-4f3d-9d9b-5b1d150c01ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_938470c7-aba2-482c-a392-0a36e57a2cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_cacec00e-99f0-4372-ad4a-fac3ba68c03d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_938470c7-aba2-482c-a392-0a36e57a2cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/Business" xlink:type="simple" xlink:href="isee-20211231.xsd#Business"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/Business" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_286a7d7d-9f11-4f6f-b55a-146e2531c349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_5a96a355-412e-47fc-af85-bbda9049c62f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_286a7d7d-9f11-4f6f-b55a-146e2531c349" xlink:to="loc_us-gaap_NatureOfOperations_5a96a355-412e-47fc-af85-bbda9049c62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/BusinessDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#BusinessDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/BusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_532e6661-8ffb-4e3e-80f0-afb71b4609f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f4a267-98a8-42da-a25d-77c33f80fda0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_532e6661-8ffb-4e3e-80f0-afb71b4609f0" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f4a267-98a8-42da-a25d-77c33f80fda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_081902de-f695-4641-9e19-673ba8374c2a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f4a267-98a8-42da-a25d-77c33f80fda0" xlink:to="loc_srt_ProductOrServiceAxis_081902de-f695-4641-9e19-673ba8374c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_249800d8-34fe-4535-80a7-0699c40c1971" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_081902de-f695-4641-9e19-673ba8374c2a" xlink:to="loc_srt_ProductsAndServicesDomain_249800d8-34fe-4535-80a7-0699c40c1971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AdenoAssociatedVirusMediatedGeneTherapyProgramMember_d830b5a5-cb19-4b82-8926-f1e0bb471399" xlink:href="isee-20211231.xsd#isee_AdenoAssociatedVirusMediatedGeneTherapyProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_249800d8-34fe-4535-80a7-0699c40c1971" xlink:to="loc_isee_AdenoAssociatedVirusMediatedGeneTherapyProgramMember_d830b5a5-cb19-4b82-8926-f1e0bb471399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e57399ff-a753-4cc8-afb8-a6c6b5daa9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_94f4a267-98a8-42da-a25d-77c33f80fda0" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e57399ff-a753-4cc8-afb8-a6c6b5daa9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_NumberOfProductCandidatesInPreclinicalDevelopment_bdf85959-556e-4702-a533-c7593a4a80db" xlink:href="isee-20211231.xsd#isee_NumberOfProductCandidatesInPreclinicalDevelopment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e57399ff-a753-4cc8-afb8-a6c6b5daa9bc" xlink:to="loc_isee_NumberOfProductCandidatesInPreclinicalDevelopment_bdf85959-556e-4702-a533-c7593a4a80db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="isee-20211231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a68262dc-5e61-458e-ac3f-258910398def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_0971c1d4-a126-4815-82ed-d6bdc59ce216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a68262dc-5e61-458e-ac3f-258910398def" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_0971c1d4-a126-4815-82ed-d6bdc59ce216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="isee-20211231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a4b9e99e-1b19-4220-8ef0-0029b65a1d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a4b9e99e-1b19-4220-8ef0-0029b65a1d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_a427644e-b4af-42c8-bbd4-31c65e42ef17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_a427644e-b4af-42c8-bbd4-31c65e42ef17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_49a61bb2-2cd5-4193-9ca0-e016c49d6844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_49a61bb2-2cd5-4193-9ca0-e016c49d6844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_decda945-14e9-4882-aef6-55f45b4bc894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_UseOfEstimates_decda945-14e9-4882-aef6-55f45b4bc894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6f1dcf86-4b98-42e7-8d3e-6c20972a9866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6f1dcf86-4b98-42e7-8d3e-6c20972a9866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_7ffe24f3-4276-40e5-8845-9d8e9706a9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_7ffe24f3-4276-40e5-8845-9d8e9706a9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_f49d3684-787f-4985-8f8c-3b72367fbef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_f49d3684-787f-4985-8f8c-3b72367fbef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ConcentrationOfSuppliersPolicyPolicyTextBlock_7d4f60d4-9a0e-4915-9982-f6a95b784642" xlink:href="isee-20211231.xsd#isee_ConcentrationOfSuppliersPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_isee_ConcentrationOfSuppliersPolicyPolicyTextBlock_7d4f60d4-9a0e-4915-9982-f6a95b784642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_55128c08-62d2-4f87-8b36-50e6a5bbe819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_55128c08-62d2-4f87-8b36-50e6a5bbe819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_c63c7845-b6c7-430e-9ce8-5412fa3c5b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_c63c7845-b6c7-430e-9ce8-5412fa3c5b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_91ca6d83-714c-4e06-accb-0024b44f79e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_91ca6d83-714c-4e06-accb-0024b44f79e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_64c56c12-cf85-4a67-818e-d671af869e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_64c56c12-cf85-4a67-818e-d671af869e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_9aae32db-437e-4b63-b91a-62b0f3a3af62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_9aae32db-437e-4b63-b91a-62b0f3a3af62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_ecea653b-d669-4edd-bca6-1f76cb74e38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_ecea653b-d669-4edd-bca6-1f76cb74e38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0e885073-e61e-440c-a5c6-bf68d88680d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0e885073-e61e-440c-a5c6-bf68d88680d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_36bd9e10-05b0-49de-a1a3-318fbd63a079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b78bd503-4a7d-49d5-8acd-1883f268bfd3" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_36bd9e10-05b0-49de-a1a3-318fbd63a079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="isee-20211231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a54ab7cc-7884-49b1-b477-b03fff8fada5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ca2e7bdd-e66d-4b92-b867-0bc4d1e293cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a54ab7cc-7884-49b1-b477-b03fff8fada5" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ca2e7bdd-e66d-4b92-b867-0bc4d1e293cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_88a269ff-5c9d-48c0-a2f2-68c89efff1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a54ab7cc-7884-49b1-b477-b03fff8fada5" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_88a269ff-5c9d-48c0-a2f2-68c89efff1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicInformationDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#SummaryofSignificantAccountingPoliciesSegmentandGeographicInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0f1d8c5a-492e-42ad-a3e4-fa982370e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_ad867a25-e875-41ec-b25a-59ab13f2cfce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0f1d8c5a-492e-42ad-a3e4-fa982370e2cd" xlink:to="loc_us-gaap_NumberOfOperatingSegments_ad867a25-e875-41ec-b25a-59ab13f2cfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_0ed51305-6f4e-473e-bd06-feb6b4697813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0f1d8c5a-492e-42ad-a3e4-fa982370e2cd" xlink:to="loc_us-gaap_NumberOfReportableSegments_0ed51305-6f4e-473e-bd06-feb6b4697813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_584a8f0c-5b8b-4c40-875f-33c2b457a1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_CashAndCashEquivalentsAndDebtSecuritiesAvailableForSale_e7ba8ebe-f436-43b7-a9a1-c922dbe84da0" xlink:href="isee-20211231.xsd#isee_CashAndCashEquivalentsAndDebtSecuritiesAvailableForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_584a8f0c-5b8b-4c40-875f-33c2b457a1ea" xlink:to="loc_isee_CashAndCashEquivalentsAndDebtSecuritiesAvailableForSale_e7ba8ebe-f436-43b7-a9a1-c922dbe84da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d675d28c-ed77-4678-8d87-4e771b772523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8861cebd-49e0-4cfd-88d5-666b3c6d4aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d675d28c-ed77-4678-8d87-4e771b772523" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8861cebd-49e0-4cfd-88d5-666b3c6d4aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_52c13635-7ed4-40cd-b69c-faa51c925274" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8861cebd-49e0-4cfd-88d5-666b3c6d4aaf" xlink:to="loc_srt_RangeAxis_52c13635-7ed4-40cd-b69c-faa51c925274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ce5eeba1-8980-4a8e-bf18-f8dcdaf2fa83" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_52c13635-7ed4-40cd-b69c-faa51c925274" xlink:to="loc_srt_RangeMember_ce5eeba1-8980-4a8e-bf18-f8dcdaf2fa83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dfef76e5-4ef9-44fe-8bfe-80ac42ebd7c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ce5eeba1-8980-4a8e-bf18-f8dcdaf2fa83" xlink:to="loc_srt_MinimumMember_dfef76e5-4ef9-44fe-8bfe-80ac42ebd7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c5bfb40c-1237-42d3-a1ac-9537b456ab22" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ce5eeba1-8980-4a8e-bf18-f8dcdaf2fa83" xlink:to="loc_srt_MaximumMember_c5bfb40c-1237-42d3-a1ac-9537b456ab22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ab5bbb8-7548-4a2a-93f9-954f9059f09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8861cebd-49e0-4cfd-88d5-666b3c6d4aaf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ab5bbb8-7548-4a2a-93f9-954f9059f09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_02e904f9-4aa8-49eb-93ac-4cc550fa9934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ab5bbb8-7548-4a2a-93f9-954f9059f09c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_02e904f9-4aa8-49eb-93ac-4cc550fa9934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesShareBasedCompensationDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#SummaryofSignificantAccountingPoliciesShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_316cfc8f-be92-4813-89cf-2070a862ede2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dd008242-5e46-4eae-854a-e2fcd2d8dc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_316cfc8f-be92-4813-89cf-2070a862ede2" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dd008242-5e46-4eae-854a-e2fcd2d8dc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ea2692f7-9b85-45c1-b12c-d3483e323125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dd008242-5e46-4eae-854a-e2fcd2d8dc1d" xlink:to="loc_us-gaap_AwardTypeAxis_ea2692f7-9b85-45c1-b12c-d3483e323125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27d8523a-3d2b-4ba2-b6e6-8a9ac1f70078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ea2692f7-9b85-45c1-b12c-d3483e323125" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27d8523a-3d2b-4ba2-b6e6-8a9ac1f70078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_aee04bd3-ffaa-406a-9512-49a2fd3b0aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27d8523a-3d2b-4ba2-b6e6-8a9ac1f70078" xlink:to="loc_us-gaap_EmployeeStockMember_aee04bd3-ffaa-406a-9512-49a2fd3b0aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_57555a15-48ca-4116-a2ed-1f8528d24841" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dd008242-5e46-4eae-854a-e2fcd2d8dc1d" xlink:to="loc_srt_RangeAxis_57555a15-48ca-4116-a2ed-1f8528d24841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bd8e6392-f042-43b8-a7d3-e2e1ad81c68f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_57555a15-48ca-4116-a2ed-1f8528d24841" xlink:to="loc_srt_RangeMember_bd8e6392-f042-43b8-a7d3-e2e1ad81c68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9488463b-37ef-410c-aa63-17284c4d1be4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bd8e6392-f042-43b8-a7d3-e2e1ad81c68f" xlink:to="loc_srt_MaximumMember_9488463b-37ef-410c-aa63-17284c4d1be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_389974cb-9932-47b3-9b84-597f17688437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dd008242-5e46-4eae-854a-e2fcd2d8dc1d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_389974cb-9932-47b3-9b84-597f17688437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a1c90a02-ffdb-4d43-bcb6-764b0488e80f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_389974cb-9932-47b3-9b84-597f17688437" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a1c90a02-ffdb-4d43-bcb6-764b0488e80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e258f8d0-bf3d-4b01-9a2b-49e3e36d7cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_389974cb-9932-47b3-9b84-597f17688437" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e258f8d0-bf3d-4b01-9a2b-49e3e36d7cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWithholdingPeriod_2bae7f66-0698-4e21-9ddc-d6af85af38db" xlink:href="isee-20211231.xsd#isee_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWithholdingPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_389974cb-9932-47b3-9b84-597f17688437" xlink:to="loc_isee_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWithholdingPeriod_2bae7f66-0698-4e21-9ddc-d6af85af38db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#SummaryofSignificantAccountingPoliciesScheduleofWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1f7b8a84-8314-4eef-a4a7-e11194bd5e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31415a60-d880-4507-997a-75203510946b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1f7b8a84-8314-4eef-a4a7-e11194bd5e95" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31415a60-d880-4507-997a-75203510946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a61a8990-501b-4906-81a3-9da302e98356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31415a60-d880-4507-997a-75203510946b" xlink:to="loc_us-gaap_AwardTypeAxis_a61a8990-501b-4906-81a3-9da302e98356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7650811-2a9c-4d23-a14b-eb4066c9e49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a61a8990-501b-4906-81a3-9da302e98356" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7650811-2a9c-4d23-a14b-eb4066c9e49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7c2b1dfe-c940-4588-b6ea-0b3fcca3a110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7650811-2a9c-4d23-a14b-eb4066c9e49c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7c2b1dfe-c940-4588-b6ea-0b3fcca3a110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8693155a-2e70-4893-a1f3-877a13dc4250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_31415a60-d880-4507-997a-75203510946b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8693155a-2e70-4893-a1f3-877a13dc4250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b1b47097-1b71-4d46-920b-5972de3cea13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8693155a-2e70-4893-a1f3-877a13dc4250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b1b47097-1b71-4d46-920b-5972de3cea13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3d747e34-39e4-4aca-910f-7862c92c7878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8693155a-2e70-4893-a1f3-877a13dc4250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3d747e34-39e4-4aca-910f-7862c92c7878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_ed8ff434-f92e-4c58-b130-88290c589286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8693155a-2e70-4893-a1f3-877a13dc4250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_ed8ff434-f92e-4c58-b130-88290c589286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_460f4989-5e16-4a50-84ab-61de56462aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8693155a-2e70-4893-a1f3-877a13dc4250" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_460f4989-5e16-4a50-84ab-61de56462aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dd3bfa03-a835-4d0a-aafc-2d3baea75da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8693155a-2e70-4893-a1f3-877a13dc4250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dd3bfa03-a835-4d0a-aafc-2d3baea75da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#SummaryofSignificantAccountingPoliciesScheduleofSharebasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b826b4ec-6592-4cce-934e-3b03ccad573e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e929da8f-08ff-42cd-8f01-cce9d40fec3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b826b4ec-6592-4cce-934e-3b03ccad573e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e929da8f-08ff-42cd-8f01-cce9d40fec3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3789e984-8f77-46a9-88be-2cadadef63d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e929da8f-08ff-42cd-8f01-cce9d40fec3f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3789e984-8f77-46a9-88be-2cadadef63d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f6766944-8913-4663-bb22-5a93843c91b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3789e984-8f77-46a9-88be-2cadadef63d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f6766944-8913-4663-bb22-5a93843c91b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_692881bb-990b-4cce-af6a-79d5e40c7610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f6766944-8913-4663-bb22-5a93843c91b8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_692881bb-990b-4cce-af6a-79d5e40c7610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d1ca3da1-aa3b-4f2b-8f8a-4ab613f6dae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f6766944-8913-4663-bb22-5a93843c91b8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d1ca3da1-aa3b-4f2b-8f8a-4ab613f6dae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1c0ae450-876a-4a0c-a630-d531a50a30ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e929da8f-08ff-42cd-8f01-cce9d40fec3f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1c0ae450-876a-4a0c-a630-d531a50a30ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_be4812bf-ba6e-466c-813c-317b96e608a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1c0ae450-876a-4a0c-a630-d531a50a30ba" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_be4812bf-ba6e-466c-813c-317b96e608a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommonStock" xlink:type="simple" xlink:href="isee-20211231.xsd#CommonStock"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_df13a5d6-e600-465c-a667-34ee4065124b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_783b0696-e74c-42f6-9527-803beaeb1494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df13a5d6-e600-465c-a667-34ee4065124b" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_783b0696-e74c-42f6-9527-803beaeb1494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommonStockNarrativeDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#CommonStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7db6046b-8166-4927-94ab-e7dc68887f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_43ebc130-5499-4754-ad8d-1ad31db3bd08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7db6046b-8166-4927-94ab-e7dc68887f4b" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_43ebc130-5499-4754-ad8d-1ad31db3bd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_39134d15-4fff-40e6-805e-8ff3b954f5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43ebc130-5499-4754-ad8d-1ad31db3bd08" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_39134d15-4fff-40e6-805e-8ff3b954f5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52d30ce5-4c76-4f81-b9d6-38ef03ca99b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_39134d15-4fff-40e6-805e-8ff3b954f5aa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52d30ce5-4c76-4f81-b9d6-38ef03ca99b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UnderwrittenOfferingMember_8f9b6f13-5053-42af-8d6e-4d2caf4aa927" xlink:href="isee-20211231.xsd#isee_UnderwrittenOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52d30ce5-4c76-4f81-b9d6-38ef03ca99b1" xlink:to="loc_isee_UnderwrittenOfferingMember_8f9b6f13-5053-42af-8d6e-4d2caf4aa927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UnderwrittenOfferingUnderwritersMember_96e15a11-ec3b-4eea-a345-0ba08460f938" xlink:href="isee-20211231.xsd#isee_UnderwrittenOfferingUnderwritersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52d30ce5-4c76-4f81-b9d6-38ef03ca99b1" xlink:to="loc_isee_UnderwrittenOfferingUnderwritersMember_96e15a11-ec3b-4eea-a345-0ba08460f938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_2cbf0a6e-7ae0-4716-a8ee-1446fb54e7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52d30ce5-4c76-4f81-b9d6-38ef03ca99b1" xlink:to="loc_us-gaap_PrivatePlacementMember_2cbf0a6e-7ae0-4716-a8ee-1446fb54e7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PrivatePlacementUnderwritersMember_671f21ea-e871-4153-a4dd-e3a3739bf908" xlink:href="isee-20211231.xsd#isee_PrivatePlacementUnderwritersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52d30ce5-4c76-4f81-b9d6-38ef03ca99b1" xlink:to="loc_isee_PrivatePlacementUnderwritersMember_671f21ea-e871-4153-a4dd-e3a3739bf908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PublicStockOfferingMember_4dc32033-0f25-4221-b5a2-d4d5a5c0b5c3" xlink:href="isee-20211231.xsd#isee_PublicStockOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52d30ce5-4c76-4f81-b9d6-38ef03ca99b1" xlink:to="loc_isee_PublicStockOfferingMember_4dc32033-0f25-4221-b5a2-d4d5a5c0b5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_d7a2fbb5-81e5-4f0d-bb77-465c00b4518e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52d30ce5-4c76-4f81-b9d6-38ef03ca99b1" xlink:to="loc_us-gaap_OverAllotmentOptionMember_d7a2fbb5-81e5-4f0d-bb77-465c00b4518e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1df0060b-febc-4995-8a65-4206d4216e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43ebc130-5499-4754-ad8d-1ad31db3bd08" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1df0060b-febc-4995-8a65-4206d4216e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b167c53f-7886-4cc5-949c-c362ff9f9de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1df0060b-febc-4995-8a65-4206d4216e8a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b167c53f-7886-4cc5-949c-c362ff9f9de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_96a3a0ed-6772-4484-99be-666c4a102416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b167c53f-7886-4cc5-949c-c362ff9f9de1" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_96a3a0ed-6772-4484-99be-666c4a102416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_594d17ed-7d49-4cf3-8bad-c6361eb13258" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43ebc130-5499-4754-ad8d-1ad31db3bd08" xlink:to="loc_srt_CounterpartyNameAxis_594d17ed-7d49-4cf3-8bad-c6361eb13258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f24f6260-42c6-46b1-8cf8-1f9b03557cb4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_594d17ed-7d49-4cf3-8bad-c6361eb13258" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f24f6260-42c6-46b1-8cf8-1f9b03557cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityOfMassachusettsUMassMember_960a68c8-9d76-4012-94e9-71574c06e82d" xlink:href="isee-20211231.xsd#isee_UniversityOfMassachusettsUMassMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f24f6260-42c6-46b1-8cf8-1f9b03557cb4" xlink:to="loc_isee_UniversityOfMassachusettsUMassMember_960a68c8-9d76-4012-94e9-71574c06e82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cd80d08d-3088-42e6-9f02-90e9492cf82a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43ebc130-5499-4754-ad8d-1ad31db3bd08" xlink:to="loc_srt_ProductOrServiceAxis_cd80d08d-3088-42e6-9f02-90e9492cf82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_58019a20-3c79-467f-b80d-d681f085bd52" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_cd80d08d-3088-42e6-9f02-90e9492cf82a" xlink:to="loc_srt_ProductsAndServicesDomain_58019a20-3c79-467f-b80d-d681f085bd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MiniCEP290Member_4ea5d53d-00e6-4d6c-916d-97a40d21625d" xlink:href="isee-20211231.xsd#isee_MiniCEP290Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_58019a20-3c79-467f-b80d-d681f085bd52" xlink:to="loc_isee_MiniCEP290Member_4ea5d53d-00e6-4d6c-916d-97a40d21625d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_150b85d8-4f3e-4eca-a186-3082b1fc4c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_43ebc130-5499-4754-ad8d-1ad31db3bd08" xlink:to="loc_us-gaap_ClassOfStockLineItems_150b85d8-4f3e-4eca-a186-3082b1fc4c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a687c008-417e-4135-ac81-030ba96857c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_150b85d8-4f3e-4eca-a186-3082b1fc4c55" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a687c008-417e-4135-ac81-030ba96857c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_aac4484f-79a8-409a-ab16-8704472e1fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_150b85d8-4f3e-4eca-a186-3082b1fc4c55" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_aac4484f-79a8-409a-ab16-8704472e1fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_d417e996-091a-40ef-9a86-78a055126113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_150b85d8-4f3e-4eca-a186-3082b1fc4c55" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_d417e996-091a-40ef-9a86-78a055126113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a1dbbb2d-17e0-41f7-a1de-336e5984cdce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_150b85d8-4f3e-4eca-a186-3082b1fc4c55" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a1dbbb2d-17e0-41f7-a1de-336e5984cdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2428dfc6-8896-4470-8222-82faed624786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_150b85d8-4f3e-4eca-a186-3082b1fc4c55" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2428dfc6-8896-4470-8222-82faed624786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d9cdc9e-f7c1-4247-b796-ae6901964ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_150b85d8-4f3e-4eca-a186-3082b1fc4c55" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d9cdc9e-f7c1-4247-b796-ae6901964ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetIncomeLossPerCommonShare" xlink:type="simple" xlink:href="isee-20211231.xsd#NetIncomeLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetIncomeLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a4b79147-a81d-4df1-8a5f-f33c75e681f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_f0fe2bb8-7e5e-4cc8-9daa-0c30b0c077d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a4b79147-a81d-4df1-8a5f-f33c75e681f4" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_f0fe2bb8-7e5e-4cc8-9daa-0c30b0c077d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetIncomeLossPerCommonShareTables" xlink:type="simple" xlink:href="isee-20211231.xsd#NetIncomeLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetIncomeLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f1f54711-8daa-4419-ba75-4939b740aa35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_97057d1e-c7af-489b-9c39-195bbfa66fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f1f54711-8daa-4419-ba75-4939b740aa35" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_97057d1e-c7af-489b-9c39-195bbfa66fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_8f412f23-4a48-45e5-8698-3d2850317c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f1f54711-8daa-4419-ba75-4939b740aa35" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_8f412f23-4a48-45e5-8698-3d2850317c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetIncomeLossPerCommonShareNarrativeDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#NetIncomeLossPerCommonShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetIncomeLossPerCommonShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4f4fed3c-95a1-4a9d-b505-f70645885414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_478d9346-a958-47db-9d68-7b00c4878d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4f4fed3c-95a1-4a9d-b505-f70645885414" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_478d9346-a958-47db-9d68-7b00c4878d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetIncomeLossPerCommonShareScheduleofBasicandDilutedNetIncomeLossPerCommonShareDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#NetIncomeLossPerCommonShareScheduleofBasicandDilutedNetIncomeLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetIncomeLossPerCommonShareScheduleofBasicandDilutedNetIncomeLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6be2609e-6bc1-42b7-9684-1e7dab242a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_733fb69f-856e-4477-bd8a-a8fe9d2e0f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6be2609e-6bc1-42b7-9684-1e7dab242a25" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_733fb69f-856e-4477-bd8a-a8fe9d2e0f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_27fa1269-fd93-4259-8496-8690bca3079c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_733fb69f-856e-4477-bd8a-a8fe9d2e0f65" xlink:to="loc_us-gaap_NetIncomeLoss_27fa1269-fd93-4259-8496-8690bca3079c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_35166809-1e1a-4c58-805e-09152428fbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_733fb69f-856e-4477-bd8a-a8fe9d2e0f65" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_35166809-1e1a-4c58-805e-09152428fbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b754a6c3-4ce5-4107-bb0c-7fa0a656f2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_733fb69f-856e-4477-bd8a-a8fe9d2e0f65" xlink:to="loc_us-gaap_EarningsPerShareBasic_b754a6c3-4ce5-4107-bb0c-7fa0a656f2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_240a2378-1a0d-4dab-827e-2784674327be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_733fb69f-856e-4477-bd8a-a8fe9d2e0f65" xlink:to="loc_us-gaap_EarningsPerShareDiluted_240a2378-1a0d-4dab-827e-2784674327be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/NetIncomeLossPerCommonShareScheduleofPotentiallyDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#NetIncomeLossPerCommonShareScheduleofPotentiallyDilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/NetIncomeLossPerCommonShareScheduleofPotentiallyDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8f3077cf-f9a6-4d5f-889f-6104e9caae3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec051199-0f46-4fa3-842a-2c602f118c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f3077cf-f9a6-4d5f-889f-6104e9caae3f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec051199-0f46-4fa3-842a-2c602f118c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d412a0c-12da-467a-a843-1beb6fd3f32d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec051199-0f46-4fa3-842a-2c602f118c66" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d412a0c-12da-467a-a843-1beb6fd3f32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ed7a88a-a85e-4eb4-a6f6-5bc4be63c3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d412a0c-12da-467a-a843-1beb6fd3f32d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ed7a88a-a85e-4eb4-a6f6-5bc4be63c3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_EmployeeAndNonemployeeStockOptionMember_68709f5a-0772-4731-a2d6-718e2e480418" xlink:href="isee-20211231.xsd#isee_EmployeeAndNonemployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ed7a88a-a85e-4eb4-a6f6-5bc4be63c3cd" xlink:to="loc_isee_EmployeeAndNonemployeeStockOptionMember_68709f5a-0772-4731-a2d6-718e2e480418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d7d11fa2-c7df-4c6d-a89d-42a5b8b4ee31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ed7a88a-a85e-4eb4-a6f6-5bc4be63c3cd" xlink:to="loc_us-gaap_RestrictedStockMember_d7d11fa2-c7df-4c6d-a89d-42a5b8b4ee31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_25ca8122-2115-41db-8051-bc8f5235e1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec051199-0f46-4fa3-842a-2c602f118c66" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_25ca8122-2115-41db-8051-bc8f5235e1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3b54ecd4-9ac1-4764-a06f-f57d009d43bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_25ca8122-2115-41db-8051-bc8f5235e1ad" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3b54ecd4-9ac1-4764-a06f-f57d009d43bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecurities" xlink:type="simple" xlink:href="isee-20211231.xsd#CashCashEquivalentsandAvailableforSaleSecurities"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_299f4fe9-098d-4853-b604-280455da9e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_d3df9a08-ad5b-43d7-912f-8609d3ca3be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_299f4fe9-098d-4853-b604-280455da9e63" xlink:to="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_d3df9a08-ad5b-43d7-912f-8609d3ca3be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="isee-20211231.xsd#CashCashEquivalentsandAvailableforSaleSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_fcd0ac34-f2c1-4d47-b36c-c1865f12e2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_e20e4cf6-9b92-49d9-9781-65622f18b1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_fcd0ac34-f2c1-4d47-b36c-c1865f12e2f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_e20e4cf6-9b92-49d9-9781-65622f18b1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#CashCashEquivalentsandAvailableforSaleSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_de93aa51-9a68-48c1-8e60-df77c5994eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_67bac52c-8eb2-497f-8263-99509d1ccf64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_de93aa51-9a68-48c1-8e60-df77c5994eab" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_67bac52c-8eb2-497f-8263-99509d1ccf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_c6e9cc82-726c-443e-95ee-e80deb982704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_de93aa51-9a68-48c1-8e60-df77c5994eab" xlink:to="loc_us-gaap_Cash_c6e9cc82-726c-443e-95ee-e80deb982704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_2440cc4c-fa4b-42f9-b59c-7a638971ff75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_de93aa51-9a68-48c1-8e60-df77c5994eab" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_2440cc4c-fa4b-42f9-b59c-7a638971ff75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c706b40f-56ad-4eb3-bffc-35250f76c784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_de93aa51-9a68-48c1-8e60-df77c5994eab" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c706b40f-56ad-4eb3-bffc-35250f76c784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#CashCashEquivalentsandAvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CashCashEquivalentsandAvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_6d3af50d-6b1f-40ee-aacc-832640bae6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e2cbfd6b-0d7d-4bbf-ad3b-57f3b53c79ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract_6d3af50d-6b1f-40ee-aacc-832640bae6b1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e2cbfd6b-0d7d-4bbf-ad3b-57f3b53c79ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_fffd9323-db90-4c49-bc19-90b1197fd990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e2cbfd6b-0d7d-4bbf-ad3b-57f3b53c79ee" xlink:to="loc_us-gaap_FinancialInstrumentAxis_fffd9323-db90-4c49-bc19-90b1197fd990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9103603c-3aee-4ed2-b7d3-203248527040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fffd9323-db90-4c49-bc19-90b1197fd990" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9103603c-3aee-4ed2-b7d3-203248527040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_ef7d1290-0f9f-4822-85e5-d39c8c1c3925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9103603c-3aee-4ed2-b7d3-203248527040" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_ef7d1290-0f9f-4822-85e5-d39c8c1c3925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d2630109-1dff-4501-8f9e-dafb4b07d825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9103603c-3aee-4ed2-b7d3-203248527040" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d2630109-1dff-4501-8f9e-dafb4b07d825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_729ff3ca-9c3c-45bd-8e02-6da7d59b3dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9103603c-3aee-4ed2-b7d3-203248527040" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_729ff3ca-9c3c-45bd-8e02-6da7d59b3dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SupranationalSecuritiesMember_e283695e-bd0e-4cba-9c62-7187e33f65a8" xlink:href="isee-20211231.xsd#isee_SupranationalSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9103603c-3aee-4ed2-b7d3-203248527040" xlink:to="loc_isee_SupranationalSecuritiesMember_e283695e-bd0e-4cba-9c62-7187e33f65a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6f351a78-99da-488e-8e98-a5221ce457ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e2cbfd6b-0d7d-4bbf-ad3b-57f3b53c79ee" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6f351a78-99da-488e-8e98-a5221ce457ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_04c4c27f-fd02-4012-ac77-c4cc5b5679b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6f351a78-99da-488e-8e98-a5221ce457ee" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_04c4c27f-fd02-4012-ac77-c4cc5b5679b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_349b8ab8-3732-4463-a33c-590f60631b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6f351a78-99da-488e-8e98-a5221ce457ee" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_349b8ab8-3732-4463-a33c-590f60631b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5d0b0fea-03e6-467d-8ce3-3cd0692d8e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6f351a78-99da-488e-8e98-a5221ce457ee" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5d0b0fea-03e6-467d-8ce3-3cd0692d8e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c3fb5cd-e1d9-4e78-9689-46861ecc0c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6f351a78-99da-488e-8e98-a5221ce457ee" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c3fb5cd-e1d9-4e78-9689-46861ecc0c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="isee-20211231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c540c1d0-3b75-4e79-b7f8-33869d3c5a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_9e968216-cb15-48a6-a646-77a7d437f2da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c540c1d0-3b75-4e79-b7f8-33869d3c5a01" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_9e968216-cb15-48a6-a646-77a7d437f2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="isee-20211231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_53b23320-1fc1-459f-aea0-b3031e367642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5806c398-cd79-48ab-98d1-a6746793048b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_53b23320-1fc1-459f-aea0-b3031e367642" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5806c398-cd79-48ab-98d1-a6746793048b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b23e4cd2-6d73-4376-8ca1-0ccb84ce2ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f403a116-1cfb-4746-9f64-311e41902570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b23e4cd2-6d73-4376-8ca1-0ccb84ce2ea2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f403a116-1cfb-4746-9f64-311e41902570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b839fc3b-a10f-4380-94fb-49d99a707fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f403a116-1cfb-4746-9f64-311e41902570" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b839fc3b-a10f-4380-94fb-49d99a707fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_08f3f7f7-d7b8-4b25-82d4-e0b71cdd817d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b839fc3b-a10f-4380-94fb-49d99a707fed" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_08f3f7f7-d7b8-4b25-82d4-e0b71cdd817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_934a26fa-9f58-4b3c-8b94-feb064491dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_08f3f7f7-d7b8-4b25-82d4-e0b71cdd817d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_934a26fa-9f58-4b3c-8b94-feb064491dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bc9a3503-bcc0-4d58-81b3-9818cced0eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f403a116-1cfb-4746-9f64-311e41902570" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bc9a3503-bcc0-4d58-81b3-9818cced0eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8eafdb6b-516b-4412-9330-5e15b3f03e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bc9a3503-bcc0-4d58-81b3-9818cced0eb3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8eafdb6b-516b-4412-9330-5e15b3f03e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5eff9688-8d79-4643-b65e-58f66f8c65c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8eafdb6b-516b-4412-9330-5e15b3f03e0b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5eff9688-8d79-4643-b65e-58f66f8c65c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_647e8781-994e-4908-8a34-ef0e9ed607c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8eafdb6b-516b-4412-9330-5e15b3f03e0b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_647e8781-994e-4908-8a34-ef0e9ed607c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_53576aab-a001-4009-bef6-c08b2ae83ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8eafdb6b-516b-4412-9330-5e15b3f03e0b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_53576aab-a001-4009-bef6-c08b2ae83ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e0a16a3d-0f94-4fab-8bcf-a1292b5ad724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f403a116-1cfb-4746-9f64-311e41902570" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e0a16a3d-0f94-4fab-8bcf-a1292b5ad724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d52cf1a8-2b07-4a03-868f-a0c712bbdb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e0a16a3d-0f94-4fab-8bcf-a1292b5ad724" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d52cf1a8-2b07-4a03-868f-a0c712bbdb6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_033e49f0-597c-4324-b1cf-646180eaad9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d52cf1a8-2b07-4a03-868f-a0c712bbdb6a" xlink:to="loc_us-gaap_MoneyMarketFundsMember_033e49f0-597c-4324-b1cf-646180eaad9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_2c2f700a-6090-4b2f-b961-89e6f3e083b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d52cf1a8-2b07-4a03-868f-a0c712bbdb6a" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_2c2f700a-6090-4b2f-b961-89e6f3e083b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_691aa91c-f909-408b-880d-2bfd00a90f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d52cf1a8-2b07-4a03-868f-a0c712bbdb6a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_691aa91c-f909-408b-880d-2bfd00a90f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_6949c306-d138-47b7-9410-ca855be74112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d52cf1a8-2b07-4a03-868f-a0c712bbdb6a" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_6949c306-d138-47b7-9410-ca855be74112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SupranationalSecuritiesMember_80d6d98f-185c-4ddd-94cc-efb23413f687" xlink:href="isee-20211231.xsd#isee_SupranationalSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d52cf1a8-2b07-4a03-868f-a0c712bbdb6a" xlink:to="loc_isee_SupranationalSecuritiesMember_80d6d98f-185c-4ddd-94cc-efb23413f687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a41f34e2-ac5f-4245-a706-20b4152c665f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f403a116-1cfb-4746-9f64-311e41902570" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a41f34e2-ac5f-4245-a706-20b4152c665f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a976f70c-421d-4629-89c3-2b15057eb787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a41f34e2-ac5f-4245-a706-20b4152c665f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a976f70c-421d-4629-89c3-2b15057eb787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_8db184fe-2759-4f1d-90e8-eee4e43bfe70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a41f34e2-ac5f-4245-a706-20b4152c665f" xlink:to="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_8db184fe-2759-4f1d-90e8-eee4e43bfe70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/LicensingandCommercializationAgreements" xlink:type="simple" xlink:href="isee-20211231.xsd#LicensingandCommercializationAgreements"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/LicensingandCommercializationAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d376e51-a7f6-4857-b81b-cd0497061b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_acad01a9-52f4-45c3-8ce2-c64c5814bf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d376e51-a7f6-4857-b81b-cd0497061b63" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_acad01a9-52f4-45c3-8ce2-c64c5814bf6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsZimuraLicenseAgreementWithArchemixCorpDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#LicensingandCommercializationAgreementsZimuraLicenseAgreementWithArchemixCorpDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsZimuraLicenseAgreementWithArchemixCorpDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b30f7e58-ea15-44e6-93e6-0d3fcf5ab12c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9d3a8c85-11b1-40d1-8862-56dfd57eec1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b30f7e58-ea15-44e6-93e6-0d3fcf5ab12c" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9d3a8c85-11b1-40d1-8862-56dfd57eec1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_5471f815-626a-42b4-a3c7-c2e7fa7310e9" xlink:href="isee-20211231.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9d3a8c85-11b1-40d1-8862-56dfd57eec1b" xlink:to="loc_isee_MilestoneEventsAxis_5471f815-626a-42b4-a3c7-c2e7fa7310e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_2009b3d8-1396-4303-82e7-a9ec74c2272d" xlink:href="isee-20211231.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_5471f815-626a-42b4-a3c7-c2e7fa7310e9" xlink:to="loc_isee_MilestoneEventsDomain_2009b3d8-1396-4303-82e7-a9ec74c2272d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_73bdeb82-3e02-4b50-a4ec-9f7231b0346c" xlink:href="isee-20211231.xsd#isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_2009b3d8-1396-4303-82e7-a9ec74c2272d" xlink:to="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_73bdeb82-3e02-4b50-a4ec-9f7231b0346c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_FirstIndicationMember_1eb65947-b515-45b3-9bc3-955db165387f" xlink:href="isee-20211231.xsd#isee_FirstIndicationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_2009b3d8-1396-4303-82e7-a9ec74c2272d" xlink:to="loc_isee_FirstIndicationMember_1eb65947-b515-45b3-9bc3-955db165387f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SecondandThirdIndicationMember_1b75dda9-28df-47b5-92a8-cbb72b5730a2" xlink:href="isee-20211231.xsd#isee_SecondandThirdIndicationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_2009b3d8-1396-4303-82e7-a9ec74c2272d" xlink:to="loc_isee_SecondandThirdIndicationMember_1b75dda9-28df-47b5-92a8-cbb72b5730a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SustainedDeliveryApplicationsMember_dc91996f-96ff-43db-b658-b724b2d712a2" xlink:href="isee-20211231.xsd#isee_SustainedDeliveryApplicationsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_2009b3d8-1396-4303-82e7-a9ec74c2272d" xlink:to="loc_isee_SustainedDeliveryApplicationsMember_dc91996f-96ff-43db-b658-b724b2d712a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedCommercialMilestonesMember_d530565b-3b68-497d-8485-c7a542fbbaf8" xlink:href="isee-20211231.xsd#isee_AchievementOfSpecifiedCommercialMilestonesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_2009b3d8-1396-4303-82e7-a9ec74c2272d" xlink:to="loc_isee_AchievementOfSpecifiedCommercialMilestonesMember_d530565b-3b68-497d-8485-c7a542fbbaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_77328181-9853-4c84-ae97-6efd5b3d4f4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9d3a8c85-11b1-40d1-8862-56dfd57eec1b" xlink:to="loc_srt_CounterpartyNameAxis_77328181-9853-4c84-ae97-6efd5b3d4f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c1defa9-10c7-44a0-81d0-7435b307737f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_77328181-9853-4c84-ae97-6efd5b3d4f4a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c1defa9-10c7-44a0-81d0-7435b307737f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ArchemixCorpMember_5a0b10e0-4dce-4a08-8e61-36c594b49995" xlink:href="isee-20211231.xsd#isee_ArchemixCorpMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c1defa9-10c7-44a0-81d0-7435b307737f" xlink:to="loc_isee_ArchemixCorpMember_5a0b10e0-4dce-4a08-8e61-36c594b49995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2954d716-aa53-4a95-85a9-16b5ba4eed30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9d3a8c85-11b1-40d1-8862-56dfd57eec1b" xlink:to="loc_srt_ProductOrServiceAxis_2954d716-aa53-4a95-85a9-16b5ba4eed30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_351574d2-1e79-4338-b0ac-5126408f8f76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2954d716-aa53-4a95-85a9-16b5ba4eed30" xlink:to="loc_srt_ProductsAndServicesDomain_351574d2-1e79-4338-b0ac-5126408f8f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_C5LicensedProductsMember_e0c5680f-fbf8-4406-b31f-24eb528fc90a" xlink:href="isee-20211231.xsd#isee_C5LicensedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_351574d2-1e79-4338-b0ac-5126408f8f76" xlink:to="loc_isee_C5LicensedProductsMember_e0c5680f-fbf8-4406-b31f-24eb528fc90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_34ad6564-f527-4edf-beab-1bc0b051deae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9d3a8c85-11b1-40d1-8862-56dfd57eec1b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_34ad6564-f527-4edf-beab-1bc0b051deae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_53d98c7d-bfb5-458f-b000-629f17c7f331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_34ad6564-f527-4edf-beab-1bc0b051deae" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_53d98c7d-bfb5-458f-b000-629f17c7f331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_cfc86478-4f04-4346-b495-c38161f68cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_53d98c7d-bfb5-458f-b000-629f17c7f331" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_cfc86478-4f04-4346-b495-c38161f68cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f42b7e62-442a-4df1-854d-9705e220b560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9d3a8c85-11b1-40d1-8862-56dfd57eec1b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f42b7e62-442a-4df1-854d-9705e220b560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6e86f1f6-dbc1-4e1c-80df-b40f7e62486c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f42b7e62-442a-4df1-854d-9705e220b560" xlink:to="loc_us-gaap_ClassOfStockDomain_6e86f1f6-dbc1-4e1c-80df-b40f7e62486c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_7ebe58d2-ea04-4a59-9f00-9be75924c237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6e86f1f6-dbc1-4e1c-80df-b40f7e62486c" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_7ebe58d2-ea04-4a59-9f00-9be75924c237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5c9a93a7-a867-4283-8054-e08138fb8e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6e86f1f6-dbc1-4e1c-80df-b40f7e62486c" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5c9a93a7-a867-4283-8054-e08138fb8e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_812518e6-7504-4755-8053-3a43e4a1aa60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9d3a8c85-11b1-40d1-8862-56dfd57eec1b" xlink:to="loc_srt_RangeAxis_812518e6-7504-4755-8053-3a43e4a1aa60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ef62b0f0-b8ce-449d-b56c-8d1790dd900d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_812518e6-7504-4755-8053-3a43e4a1aa60" xlink:to="loc_srt_RangeMember_ef62b0f0-b8ce-449d-b56c-8d1790dd900d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_44d167e6-5865-4a93-8987-179f4451e824" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ef62b0f0-b8ce-449d-b56c-8d1790dd900d" xlink:to="loc_srt_MaximumMember_44d167e6-5865-4a93-8987-179f4451e824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b7eb2b1d-df07-4538-9b40-8e155f29fe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9d3a8c85-11b1-40d1-8862-56dfd57eec1b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b7eb2b1d-df07-4538-9b40-8e155f29fe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PaymentsForLicenseFees_d69a6f70-040e-43c4-8ff5-e783b1eedede" xlink:href="isee-20211231.xsd#isee_PaymentsForLicenseFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b7eb2b1d-df07-4538-9b40-8e155f29fe9f" xlink:to="loc_isee_PaymentsForLicenseFees_d69a6f70-040e-43c4-8ff5-e783b1eedede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SharesIssuedForLicenseFees_04cbe33e-65e9-471a-85ad-afe10fe9e0aa" xlink:href="isee-20211231.xsd#isee_SharesIssuedForLicenseFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b7eb2b1d-df07-4538-9b40-8e155f29fe9f" xlink:to="loc_isee_SharesIssuedForLicenseFees_04cbe33e-65e9-471a-85ad-afe10fe9e0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_NumberOfMilestonePayments_fb7f072b-2bcb-409a-ae1e-6178da53b111" xlink:href="isee-20211231.xsd#isee_NumberOfMilestonePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b7eb2b1d-df07-4538-9b40-8e155f29fe9f" xlink:to="loc_isee_NumberOfMilestonePayments_fb7f072b-2bcb-409a-ae1e-6178da53b111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_TrialDataPeriod_f83cf0ea-8756-47cf-8181-b36cfee448c7" xlink:href="isee-20211231.xsd#isee_TrialDataPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b7eb2b1d-df07-4538-9b40-8e155f29fe9f" xlink:to="loc_isee_TrialDataPeriod_f83cf0ea-8756-47cf-8181-b36cfee448c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AmountToBePaidOnAchievementOfMilestone_bfa3a9f4-51a4-4581-878b-e89591b10a62" xlink:href="isee-20211231.xsd#isee_AmountToBePaidOnAchievementOfMilestone"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b7eb2b1d-df07-4538-9b40-8e155f29fe9f" xlink:to="loc_isee_AmountToBePaidOnAchievementOfMilestone_bfa3a9f4-51a4-4581-878b-e89591b10a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_LicensingAgreementTerm_dea6e66d-3e11-4458-a9aa-cbf0d9e0c133" xlink:href="isee-20211231.xsd#isee_LicensingAgreementTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b7eb2b1d-df07-4538-9b40-8e155f29fe9f" xlink:to="loc_isee_LicensingAgreementTerm_dea6e66d-3e11-4458-a9aa-cbf0d9e0c133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsRHOadRPLicenseAgreementwiththeUniversityofFloridaResearchFoundationandtheUniversityifPennsylvaniaDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#LicensingandCommercializationAgreementsRHOadRPLicenseAgreementwiththeUniversityofFloridaResearchFoundationandtheUniversityifPennsylvaniaDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsRHOadRPLicenseAgreementwiththeUniversityofFloridaResearchFoundationandtheUniversityifPennsylvaniaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_17064f18-559c-45e3-9a49-3347663f0f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ec0a9ae5-181b-4d41-8592-f443ec542c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_17064f18-559c-45e3-9a49-3347663f0f3a" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ec0a9ae5-181b-4d41-8592-f443ec542c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_71f646af-4afd-495a-a681-1dadda9b18ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ec0a9ae5-181b-4d41-8592-f443ec542c0c" xlink:to="loc_srt_CounterpartyNameAxis_71f646af-4afd-495a-a681-1dadda9b18ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e1a4bc82-67dc-4aec-839e-4eda0309553a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_71f646af-4afd-495a-a681-1dadda9b18ee" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e1a4bc82-67dc-4aec-839e-4eda0309553a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityofFloridaResearchFoundationUFRFMember_87cdf91c-6801-4182-b293-86861c298bda" xlink:href="isee-20211231.xsd#isee_UniversityofFloridaResearchFoundationUFRFMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e1a4bc82-67dc-4aec-839e-4eda0309553a" xlink:to="loc_isee_UniversityofFloridaResearchFoundationUFRFMember_87cdf91c-6801-4182-b293-86861c298bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_57e7fd9a-4336-4ba6-92ec-d09f62e459a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ec0a9ae5-181b-4d41-8592-f443ec542c0c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_57e7fd9a-4336-4ba6-92ec-d09f62e459a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bc30ee9f-1348-49dd-82bd-86786f6ff2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_57e7fd9a-4336-4ba6-92ec-d09f62e459a0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bc30ee9f-1348-49dd-82bd-86786f6ff2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_53f59381-c413-44a0-b698-e00a8db62ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bc30ee9f-1348-49dd-82bd-86786f6ff2de" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_53f59381-c413-44a0-b698-e00a8db62ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_49952d10-6956-42e9-8a4f-39a1a8f9df99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bc30ee9f-1348-49dd-82bd-86786f6ff2de" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_49952d10-6956-42e9-8a4f-39a1a8f9df99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ab66b430-295f-414f-9fc1-7fc1ce9c18de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ec0a9ae5-181b-4d41-8592-f443ec542c0c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ab66b430-295f-414f-9fc1-7fc1ce9c18de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3b6e1e47-ccb3-412c-b253-c0419fa0af96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ab66b430-295f-414f-9fc1-7fc1ce9c18de" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3b6e1e47-ccb3-412c-b253-c0419fa0af96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_RHOadRPLicenseAgreementMember_c2e6556b-7dff-461f-b6a4-710869461434" xlink:href="isee-20211231.xsd#isee_RHOadRPLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3b6e1e47-ccb3-412c-b253-c0419fa0af96" xlink:to="loc_isee_RHOadRPLicenseAgreementMember_c2e6556b-7dff-461f-b6a4-710869461434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_9222daca-2d62-466c-a93e-1974e3de8a50" xlink:href="isee-20211231.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ec0a9ae5-181b-4d41-8592-f443ec542c0c" xlink:to="loc_isee_MilestoneEventsAxis_9222daca-2d62-466c-a93e-1974e3de8a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_624da457-5c5a-4839-9b4f-1c1602ebc47d" xlink:href="isee-20211231.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_9222daca-2d62-466c-a93e-1974e3de8a50" xlink:to="loc_isee_MilestoneEventsDomain_624da457-5c5a-4839-9b4f-1c1602ebc47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_fc3a91d3-5342-4ede-b881-3821f0a48682" xlink:href="isee-20211231.xsd#isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_624da457-5c5a-4839-9b4f-1c1602ebc47d" xlink:to="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_fc3a91d3-5342-4ede-b881-3821f0a48682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_80d90e56-7a83-4795-8d18-868b8d305008" xlink:href="isee-20211231.xsd#isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_624da457-5c5a-4839-9b4f-1c1602ebc47d" xlink:to="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_80d90e56-7a83-4795-8d18-868b8d305008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0809e586-b424-440a-953e-8535d7e090a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ec0a9ae5-181b-4d41-8592-f443ec542c0c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0809e586-b424-440a-953e-8535d7e090a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PaymentsForLicenseFees_9667475f-3d6e-4045-9943-81b3a7de04eb" xlink:href="isee-20211231.xsd#isee_PaymentsForLicenseFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0809e586-b424-440a-953e-8535d7e090a7" xlink:to="loc_isee_PaymentsForLicenseFees_9667475f-3d6e-4045-9943-81b3a7de04eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_LicensingAgreementTerm_4cc412b8-37ff-4b3e-b513-7ac5dcafdefe" xlink:href="isee-20211231.xsd#isee_LicensingAgreementTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0809e586-b424-440a-953e-8535d7e090a7" xlink:to="loc_isee_LicensingAgreementTerm_4cc412b8-37ff-4b3e-b513-7ac5dcafdefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsBEST1LicenseAgreementwithUniversityofPennsylvaniaandUniversityofFloridaResearchFoundationDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#LicensingandCommercializationAgreementsBEST1LicenseAgreementwithUniversityofPennsylvaniaandUniversityofFloridaResearchFoundationDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsBEST1LicenseAgreementwithUniversityofPennsylvaniaandUniversityofFloridaResearchFoundationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_32090913-ff91-40eb-9b9d-b3bb7e5b60ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_88de43a8-3a3a-46c8-b49b-b692d4433b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_32090913-ff91-40eb-9b9d-b3bb7e5b60ba" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_88de43a8-3a3a-46c8-b49b-b692d4433b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_337f09af-cccc-4c12-9375-f7fc39165b5a" xlink:href="isee-20211231.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_88de43a8-3a3a-46c8-b49b-b692d4433b3c" xlink:to="loc_isee_MilestoneEventsAxis_337f09af-cccc-4c12-9375-f7fc39165b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_5f1b7996-4362-404d-8d0e-c53ad6fe178b" xlink:href="isee-20211231.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_337f09af-cccc-4c12-9375-f7fc39165b5a" xlink:to="loc_isee_MilestoneEventsDomain_5f1b7996-4362-404d-8d0e-c53ad6fe178b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_995eae95-4ce3-47b0-ac0c-2f56d48c32cf" xlink:href="isee-20211231.xsd#isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_5f1b7996-4362-404d-8d0e-c53ad6fe178b" xlink:to="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_995eae95-4ce3-47b0-ac0c-2f56d48c32cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_db3914cf-d824-4e52-8fb4-efd52757ab85" xlink:href="isee-20211231.xsd#isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_5f1b7996-4362-404d-8d0e-c53ad6fe178b" xlink:to="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_db3914cf-d824-4e52-8fb4-efd52757ab85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2c4e04b1-0be9-4f82-84a9-721a70cd1932" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_88de43a8-3a3a-46c8-b49b-b692d4433b3c" xlink:to="loc_srt_CounterpartyNameAxis_2c4e04b1-0be9-4f82-84a9-721a70cd1932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a979ad9f-6ceb-4070-8ff1-059b1de6b1c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_2c4e04b1-0be9-4f82-84a9-721a70cd1932" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a979ad9f-6ceb-4070-8ff1-059b1de6b1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityOfPennsylvaniaMember_d8747386-7f58-4290-95dd-d3d4df6fb63b" xlink:href="isee-20211231.xsd#isee_UniversityOfPennsylvaniaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a979ad9f-6ceb-4070-8ff1-059b1de6b1c5" xlink:to="loc_isee_UniversityOfPennsylvaniaMember_d8747386-7f58-4290-95dd-d3d4df6fb63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityofFloridaResearchFoundationUFRFMember_bd5f0074-a6e4-4a37-b622-6f7fd4e33b04" xlink:href="isee-20211231.xsd#isee_UniversityofFloridaResearchFoundationUFRFMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a979ad9f-6ceb-4070-8ff1-059b1de6b1c5" xlink:to="loc_isee_UniversityofFloridaResearchFoundationUFRFMember_bd5f0074-a6e4-4a37-b622-6f7fd4e33b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityOfFloridaResearchFoundationUFRFAndUniversityOfPennsylvaniaPennMember_6bf1a446-748e-414f-bb3a-7ce0be7e5a08" xlink:href="isee-20211231.xsd#isee_UniversityOfFloridaResearchFoundationUFRFAndUniversityOfPennsylvaniaPennMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a979ad9f-6ceb-4070-8ff1-059b1de6b1c5" xlink:to="loc_isee_UniversityOfFloridaResearchFoundationUFRFAndUniversityOfPennsylvaniaPennMember_6bf1a446-748e-414f-bb3a-7ce0be7e5a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b9186e1c-a5fa-452a-93b8-be3376502bac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_88de43a8-3a3a-46c8-b49b-b692d4433b3c" xlink:to="loc_srt_ProductOrServiceAxis_b9186e1c-a5fa-452a-93b8-be3376502bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_033dee51-f5bb-4fee-a49a-af0e63ae045c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b9186e1c-a5fa-452a-93b8-be3376502bac" xlink:to="loc_srt_ProductsAndServicesDomain_033dee51-f5bb-4fee-a49a-af0e63ae045c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PrimaryLicensedProductMember_70e2dc19-2c24-4b31-944a-c9587c68a0f8" xlink:href="isee-20211231.xsd#isee_PrimaryLicensedProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_033dee51-f5bb-4fee-a49a-af0e63ae045c" xlink:to="loc_isee_PrimaryLicensedProductMember_70e2dc19-2c24-4b31-944a-c9587c68a0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_OtherLicensedProductMember_52910a90-5cab-42ee-9501-cd397e48a5f2" xlink:href="isee-20211231.xsd#isee_OtherLicensedProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_033dee51-f5bb-4fee-a49a-af0e63ae045c" xlink:to="loc_isee_OtherLicensedProductMember_52910a90-5cab-42ee-9501-cd397e48a5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_204dd7b8-6277-4de9-91c8-5dbcb6167dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_88de43a8-3a3a-46c8-b49b-b692d4433b3c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_204dd7b8-6277-4de9-91c8-5dbcb6167dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2c3d5623-3fc0-436a-a636-da94ca675e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_204dd7b8-6277-4de9-91c8-5dbcb6167dfd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2c3d5623-3fc0-436a-a636-da94ca675e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_60504026-9fa6-4255-81c5-d0e6da19c667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c3d5623-3fc0-436a-a636-da94ca675e3b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_60504026-9fa6-4255-81c5-d0e6da19c667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4695108a-7fd1-42c2-adc9-030622fee879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c3d5623-3fc0-436a-a636-da94ca675e3b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4695108a-7fd1-42c2-adc9-030622fee879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e37cf0df-271a-4922-9baa-8b2cd2b1382f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_88de43a8-3a3a-46c8-b49b-b692d4433b3c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e37cf0df-271a-4922-9baa-8b2cd2b1382f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a54adf-dded-4318-9a32-78d9aa919cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e37cf0df-271a-4922-9baa-8b2cd2b1382f" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a54adf-dded-4318-9a32-78d9aa919cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_BEST1LicenseAgreementMember_58dbdacf-98de-44dd-91b7-08dc21e96d60" xlink:href="isee-20211231.xsd#isee_BEST1LicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_24a54adf-dded-4318-9a32-78d9aa919cca" xlink:to="loc_isee_BEST1LicenseAgreementMember_58dbdacf-98de-44dd-91b7-08dc21e96d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_effdd493-e3aa-4c14-b723-0f6c55b334b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_88de43a8-3a3a-46c8-b49b-b692d4433b3c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_effdd493-e3aa-4c14-b723-0f6c55b334b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PaymentsForLicenseFees_a95dbb91-e25a-49c5-ab01-b51385bc4eaa" xlink:href="isee-20211231.xsd#isee_PaymentsForLicenseFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_effdd493-e3aa-4c14-b723-0f6c55b334b5" xlink:to="loc_isee_PaymentsForLicenseFees_a95dbb91-e25a-49c5-ab01-b51385bc4eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_NumberOfLicensedProducts_440c934a-72e6-483f-b3d5-8fb438a42a4d" xlink:href="isee-20211231.xsd#isee_NumberOfLicensedProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_effdd493-e3aa-4c14-b723-0f6c55b334b5" xlink:to="loc_isee_NumberOfLicensedProducts_440c934a-72e6-483f-b3d5-8fb438a42a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_LicensingAgreementTerm_42dd696e-5bcf-48ee-8535-98bcb47f79d1" xlink:href="isee-20211231.xsd#isee_LicensingAgreementTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_effdd493-e3aa-4c14-b723-0f6c55b334b5" xlink:to="loc_isee_LicensingAgreementTerm_42dd696e-5bcf-48ee-8535-98bcb47f79d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsLicenseAgreementwithUniversityofMassachusettsfortheminiCEP290ProgramDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#LicensingandCommercializationAgreementsLicenseAgreementwithUniversityofMassachusettsfortheminiCEP290ProgramDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/LicensingandCommercializationAgreementsLicenseAgreementwithUniversityofMassachusettsfortheminiCEP290ProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f7ea1d18-5236-4c27-8b71-391c4a8741bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6ee1f59a-ae0b-4f58-b85f-e59219da8453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f7ea1d18-5236-4c27-8b71-391c4a8741bf" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6ee1f59a-ae0b-4f58-b85f-e59219da8453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3dca0662-0a0c-4311-9e87-a59176fa490a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6ee1f59a-ae0b-4f58-b85f-e59219da8453" xlink:to="loc_srt_CounterpartyNameAxis_3dca0662-0a0c-4311-9e87-a59176fa490a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_73883ac4-cb28-49b2-aa0f-b7e200902eff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_3dca0662-0a0c-4311-9e87-a59176fa490a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_73883ac4-cb28-49b2-aa0f-b7e200902eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityOfMassachusettsUMassMember_c9a7952c-72f9-4138-8003-b44a6cf497ed" xlink:href="isee-20211231.xsd#isee_UniversityOfMassachusettsUMassMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_73883ac4-cb28-49b2-aa0f-b7e200902eff" xlink:to="loc_isee_UniversityOfMassachusettsUMassMember_c9a7952c-72f9-4138-8003-b44a6cf497ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3bba5d3c-dfd6-46a0-a10e-afc20254eb11" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6ee1f59a-ae0b-4f58-b85f-e59219da8453" xlink:to="loc_srt_ProductOrServiceAxis_3bba5d3c-dfd6-46a0-a10e-afc20254eb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8ad21d1d-7097-4635-900e-c178b1654d12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3bba5d3c-dfd6-46a0-a10e-afc20254eb11" xlink:to="loc_srt_ProductsAndServicesDomain_8ad21d1d-7097-4635-900e-c178b1654d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MiniCEP290Member_821917ab-9549-46b4-b881-7aa6eccb5725" xlink:href="isee-20211231.xsd#isee_MiniCEP290Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8ad21d1d-7097-4635-900e-c178b1654d12" xlink:to="loc_isee_MiniCEP290Member_821917ab-9549-46b4-b881-7aa6eccb5725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ae6ec397-1fea-4312-a322-a95f2bb5b198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6ee1f59a-ae0b-4f58-b85f-e59219da8453" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ae6ec397-1fea-4312-a322-a95f2bb5b198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_79aa92a0-df75-4009-a8b4-dc3ed9aa38da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ae6ec397-1fea-4312-a322-a95f2bb5b198" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_79aa92a0-df75-4009-a8b4-dc3ed9aa38da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_24f11499-91d6-41be-a720-696199879fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_79aa92a0-df75-4009-a8b4-dc3ed9aa38da" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_24f11499-91d6-41be-a720-696199879fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_514a49e8-51ef-49d0-aeed-ba15a7bfb962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6ee1f59a-ae0b-4f58-b85f-e59219da8453" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_514a49e8-51ef-49d0-aeed-ba15a7bfb962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_76f3b413-9034-457e-b4c2-e4d761789cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_514a49e8-51ef-49d0-aeed-ba15a7bfb962" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_76f3b413-9034-457e-b4c2-e4d761789cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_74a156fb-220b-483b-9e63-4a1d97e79676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_76f3b413-9034-457e-b4c2-e4d761789cb6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_74a156fb-220b-483b-9e63-4a1d97e79676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f1329e9b-dab7-4f1b-a9d6-20f1ea21875c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_76f3b413-9034-457e-b4c2-e4d761789cb6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f1329e9b-dab7-4f1b-a9d6-20f1ea21875c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_8cd0ecf4-d002-40ed-92be-bb9f1b5584d6" xlink:href="isee-20211231.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6ee1f59a-ae0b-4f58-b85f-e59219da8453" xlink:to="loc_isee_MilestoneEventsAxis_8cd0ecf4-d002-40ed-92be-bb9f1b5584d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_0d7b07df-e9f0-4d63-8e8b-ebb7b07cbc3b" xlink:href="isee-20211231.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_8cd0ecf4-d002-40ed-92be-bb9f1b5584d6" xlink:to="loc_isee_MilestoneEventsDomain_0d7b07df-e9f0-4d63-8e8b-ebb7b07cbc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_3a5d10d0-fa3e-4ef2-9404-0484298516f0" xlink:href="isee-20211231.xsd#isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_0d7b07df-e9f0-4d63-8e8b-ebb7b07cbc3b" xlink:to="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_3a5d10d0-fa3e-4ef2-9404-0484298516f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_76c15d04-9548-4a5c-ad4f-3b4254f643b4" xlink:href="isee-20211231.xsd#isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_0d7b07df-e9f0-4d63-8e8b-ebb7b07cbc3b" xlink:to="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_76c15d04-9548-4a5c-ad4f-3b4254f643b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_2cf06a2d-d20f-467a-a07f-840b2709d677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6ee1f59a-ae0b-4f58-b85f-e59219da8453" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_2cf06a2d-d20f-467a-a07f-840b2709d677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SharesIssuedForLicenseFees_52da5951-c01f-416d-a7bb-d632a175f1ae" xlink:href="isee-20211231.xsd#isee_SharesIssuedForLicenseFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_2cf06a2d-d20f-467a-a07f-840b2709d677" xlink:to="loc_isee_SharesIssuedForLicenseFees_52da5951-c01f-416d-a7bb-d632a175f1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PaymentsForLicenseFees_6d368591-1ce1-48c9-9a36-ef2898675b36" xlink:href="isee-20211231.xsd#isee_PaymentsForLicenseFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_2cf06a2d-d20f-467a-a07f-840b2709d677" xlink:to="loc_isee_PaymentsForLicenseFees_6d368591-1ce1-48c9-9a36-ef2898675b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_LicensingAgreementTerm_40696d50-9bc4-4004-9cb8-be0f4039931f" xlink:href="isee-20211231.xsd#isee_LicensingAgreementTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_2cf06a2d-d20f-467a-a07f-840b2709d677" xlink:to="loc_isee_LicensingAgreementTerm_40696d50-9bc4-4004-9cb8-be0f4039931f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="isee-20211231.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_aa012021-68f1-4fd7-99ac-6e90101c0a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_b1dfa909-0dda-4798-a167-050b6557083b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_aa012021-68f1-4fd7-99ac-6e90101c0a6c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_b1dfa909-0dda-4798-a167-050b6557083b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="isee-20211231.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5224e708-d261-4c5f-a829-d9042cba3890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9a69a0ac-de83-4a32-86ca-c6685f68d846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5224e708-d261-4c5f-a829-d9042cba3890" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9a69a0ac-de83-4a32-86ca-c6685f68d846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#PropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2ae3865f-ace3-4960-9bf4-e430891c94bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f9796c66-2695-49c3-b9e1-427cc18a416c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2ae3865f-ace3-4960-9bf4-e430891c94bd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f9796c66-2695-49c3-b9e1-427cc18a416c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cdcc51e6-7774-47a1-8c05-bd010e3a9965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f9796c66-2695-49c3-b9e1-427cc18a416c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cdcc51e6-7774-47a1-8c05-bd010e3a9965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35b76888-95f3-4cfb-90e9-08ecfd1d8c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cdcc51e6-7774-47a1-8c05-bd010e3a9965" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35b76888-95f3-4cfb-90e9-08ecfd1d8c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_b6a25a40-e4da-442f-88a5-8154b7f97c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35b76888-95f3-4cfb-90e9-08ecfd1d8c53" xlink:to="loc_us-gaap_EquipmentMember_b6a25a40-e4da-442f-88a5-8154b7f97c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ComputerSoftwareandOtherOfficeEquipmentMember_0d273110-c08e-4590-b861-e47d049f8cfa" xlink:href="isee-20211231.xsd#isee_ComputerSoftwareandOtherOfficeEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35b76888-95f3-4cfb-90e9-08ecfd1d8c53" xlink:to="loc_isee_ComputerSoftwareandOtherOfficeEquipmentMember_0d273110-c08e-4590-b861-e47d049f8cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_a33e1353-7ae3-4679-9005-ce4da595d473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35b76888-95f3-4cfb-90e9-08ecfd1d8c53" xlink:to="loc_us-gaap_AutomobilesMember_a33e1353-7ae3-4679-9005-ce4da595d473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fe9a45f3-348f-4901-ad9d-c8e7bc9081c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f9796c66-2695-49c3-b9e1-427cc18a416c" xlink:to="loc_srt_RangeAxis_fe9a45f3-348f-4901-ad9d-c8e7bc9081c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_21218400-9324-483d-8b41-b5958baed6dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fe9a45f3-348f-4901-ad9d-c8e7bc9081c3" xlink:to="loc_srt_RangeMember_21218400-9324-483d-8b41-b5958baed6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_619dcfff-bbf5-47f4-8449-bc61aed0843d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_21218400-9324-483d-8b41-b5958baed6dc" xlink:to="loc_srt_MinimumMember_619dcfff-bbf5-47f4-8449-bc61aed0843d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3dc517e5-97a6-4d88-8419-d7a6ec93afba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_21218400-9324-483d-8b41-b5958baed6dc" xlink:to="loc_srt_MaximumMember_3dc517e5-97a6-4d88-8419-d7a6ec93afba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6867f07d-32d6-46cf-a164-6570cfeb318f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f9796c66-2695-49c3-b9e1-427cc18a416c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6867f07d-32d6-46cf-a164-6570cfeb318f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_86397530-ed81-418e-97f1-d5a21f252a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6867f07d-32d6-46cf-a164-6570cfeb318f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_86397530-ed81-418e-97f1-d5a21f252a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b7e02817-6be9-4531-b052-2f2e29ed0577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6867f07d-32d6-46cf-a164-6570cfeb318f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b7e02817-6be9-4531-b052-2f2e29ed0577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8c3f1542-2656-4e48-a764-f51549ba353a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6867f07d-32d6-46cf-a164-6570cfeb318f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8c3f1542-2656-4e48-a764-f51549ba353a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a8fdb131-1dbb-42f1-a9bf-8d88435393f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6867f07d-32d6-46cf-a164-6570cfeb318f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a8fdb131-1dbb-42f1-a9bf-8d88435393f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_45472a38-70b2-4ca5-a649-a089fadd3d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6867f07d-32d6-46cf-a164-6570cfeb318f" xlink:to="loc_us-gaap_Depreciation_45472a38-70b2-4ca5-a649-a089fadd3d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/IncomeTaxes" xlink:type="simple" xlink:href="isee-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_aedc16e3-3e25-46f5-9f09-c4d720f3f441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_86621872-35dc-4bf8-a528-feab772c55fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aedc16e3-3e25-46f5-9f09-c4d720f3f441" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_86621872-35dc-4bf8-a528-feab772c55fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="isee-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_86e5098e-80c9-4b77-8b53-2701fa9bf6db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_5ba55fbc-bfac-4ec3-9285-fbd2584ff0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86e5098e-80c9-4b77-8b53-2701fa9bf6db" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_5ba55fbc-bfac-4ec3-9285-fbd2584ff0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d9fb460f-acc9-4663-898c-b38ac9a989d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86e5098e-80c9-4b77-8b53-2701fa9bf6db" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d9fb460f-acc9-4663-898c-b38ac9a989d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_cb1c7696-6f0e-4e12-a1b9-0a47d36fc21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86e5098e-80c9-4b77-8b53-2701fa9bf6db" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_cb1c7696-6f0e-4e12-a1b9-0a47d36fc21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_30324f4f-5cf5-42d1-832a-f14d166d089b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86e5098e-80c9-4b77-8b53-2701fa9bf6db" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_30324f4f-5cf5-42d1-832a-f14d166d089b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_48a3bf69-f434-407e-8031-60716cd43463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_52b3464a-b3f6-4d1a-a4e2-97e055f860d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_48a3bf69-f434-407e-8031-60716cd43463" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_52b3464a-b3f6-4d1a-a4e2-97e055f860d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ada9d8bf-0b8d-43e7-9a7f-5168693acae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_52b3464a-b3f6-4d1a-a4e2-97e055f860d0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ada9d8bf-0b8d-43e7-9a7f-5168693acae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_97682884-d7bc-4183-ba35-5656a4c79e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_52b3464a-b3f6-4d1a-a4e2-97e055f860d0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_97682884-d7bc-4183-ba35-5656a4c79e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_bbe5ccb0-9c20-4899-a4f2-d304293a57c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_52b3464a-b3f6-4d1a-a4e2-97e055f860d0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_bbe5ccb0-9c20-4899-a4f2-d304293a57c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_90aa14c1-67da-452a-ad1b-e32f2f49ce9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_52b3464a-b3f6-4d1a-a4e2-97e055f860d0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_90aa14c1-67da-452a-ad1b-e32f2f49ce9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_44e17fb0-5b76-4f79-a1d9-2dde861693ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_52b3464a-b3f6-4d1a-a4e2-97e055f860d0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_44e17fb0-5b76-4f79-a1d9-2dde861693ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_d48f2328-92e3-47ab-a7ec-6f6aea94a2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_52b3464a-b3f6-4d1a-a4e2-97e055f860d0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_d48f2328-92e3-47ab-a7ec-6f6aea94a2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_61ff8bbd-ecb1-4648-8d0e-c76cec2f9909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_52b3464a-b3f6-4d1a-a4e2-97e055f860d0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_61ff8bbd-ecb1-4648-8d0e-c76cec2f9909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitExpenseDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxBenefitExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0c85121b-08a8-401f-bfc7-fadc37eda638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ab91e5c6-fa38-4e52-b577-73be03eff8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c85121b-08a8-401f-bfc7-fadc37eda638" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ab91e5c6-fa38-4e52-b577-73be03eff8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8cf1ccdb-f4d2-4c81-81c0-a166efd0fe37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ab91e5c6-fa38-4e52-b577-73be03eff8ed" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8cf1ccdb-f4d2-4c81-81c0-a166efd0fe37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_013a1759-5d61-40f2-a2fa-adb8de7efb82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ab91e5c6-fa38-4e52-b577-73be03eff8ed" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_013a1759-5d61-40f2-a2fa-adb8de7efb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9a44b50e-0473-4bc6-9894-8a8361731489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c85121b-08a8-401f-bfc7-fadc37eda638" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9a44b50e-0473-4bc6-9894-8a8361731489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e52f0d26-ae79-42b4-8241-c8375284a717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9a44b50e-0473-4bc6-9894-8a8361731489" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e52f0d26-ae79-42b4-8241-c8375284a717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c3f5c9d6-5418-47ee-a504-9b1305c7f993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9a44b50e-0473-4bc6-9894-8a8361731489" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c3f5c9d6-5418-47ee-a504-9b1305c7f993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0ef81349-5a4f-42d2-b0a7-e4c3d4e0ff18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c85121b-08a8-401f-bfc7-fadc37eda638" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0ef81349-5a4f-42d2-b0a7-e4c3d4e0ff18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/IncomeTaxesScheduleofSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#IncomeTaxesScheduleofSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/IncomeTaxesScheduleofSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4ccb90ae-272c-4d76-a1f6-65332fd97036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4ccb90ae-272c-4d76-a1f6-65332fd97036" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DeferredTaxAssetsLicenseAndTechnologyPayments_60f03cd9-3051-4a6f-a5dc-80799bcdede7" xlink:href="isee-20211231.xsd#isee_DeferredTaxAssetsLicenseAndTechnologyPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_isee_DeferredTaxAssetsLicenseAndTechnologyPayments_60f03cd9-3051-4a6f-a5dc-80799bcdede7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_bb7f89c3-d1b1-4e96-a55f-a6ec668aef4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_bb7f89c3-d1b1-4e96-a55f-a6ec668aef4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e3f4389f-a831-4b65-a7af-e02fa1223643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e3f4389f-a831-4b65-a7af-e02fa1223643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DeferredTaxLiabilitiesRightOfUseAsset_aea62bd9-e049-41d8-a37a-925090dc70a1" xlink:href="isee-20211231.xsd#isee_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_isee_DeferredTaxLiabilitiesRightOfUseAsset_aea62bd9-e049-41d8-a37a-925090dc70a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DeferredTaxAssetsLeaseObligation_28b08d12-dce6-4aa6-9c6a-33d6edae1fc6" xlink:href="isee-20211231.xsd#isee_DeferredTaxAssetsLeaseObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_isee_DeferredTaxAssetsLeaseObligation_28b08d12-dce6-4aa6-9c6a-33d6edae1fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_e06e3193-e2c6-426c-a7e6-475b3f1e8baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_e06e3193-e2c6-426c-a7e6-475b3f1e8baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_DeferredTaxAssetsOperatingLossCarryforwardsFederalStateAndLocal_61dc28b2-08c0-458d-944c-cb024d7b577a" xlink:href="isee-20211231.xsd#isee_DeferredTaxAssetsOperatingLossCarryforwardsFederalStateAndLocal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_isee_DeferredTaxAssetsOperatingLossCarryforwardsFederalStateAndLocal_61dc28b2-08c0-458d-944c-cb024d7b577a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_91f2c8f8-4f9e-4eb5-a54b-e3a3d6e50064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_91f2c8f8-4f9e-4eb5-a54b-e3a3d6e50064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_1d660152-32d2-45c3-b805-845df90c8f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_1d660152-32d2-45c3-b805-845df90c8f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8dde679c-dab5-4dd4-8234-cbf5f03dfe69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_8dde679c-dab5-4dd4-8234-cbf5f03dfe69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_de76d7e7-7502-4a2e-8681-4ce58ce60c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_de76d7e7-7502-4a2e-8681-4ce58ce60c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_95c5dcb8-4d6c-4f6b-bc81-85c14e3d46ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2a32d49f-bc0f-4bae-afed-4ed8a64fd3a3" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_95c5dcb8-4d6c-4f6b-bc81-85c14e3d46ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_aa053a47-b3e0-4c54-bc10-5f5c6e72444e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_5c2a27e0-4e9b-442d-8a05-3ba276431b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aa053a47-b3e0-4c54-bc10-5f5c6e72444e" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_5c2a27e0-4e9b-442d-8a05-3ba276431b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_242eb1d3-5604-4f89-960e-d42d0307c340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5c2a27e0-4e9b-442d-8a05-3ba276431b0f" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_242eb1d3-5604-4f89-960e-d42d0307c340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f57a7d99-8350-49d2-9a06-1370bab15507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_242eb1d3-5604-4f89-960e-d42d0307c340" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f57a7d99-8350-49d2-9a06-1370bab15507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_90e26fda-e6b2-4192-9efc-ab6f81623a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f57a7d99-8350-49d2-9a06-1370bab15507" xlink:to="loc_us-gaap_DomesticCountryMember_90e26fda-e6b2-4192-9efc-ab6f81623a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_9cdba1a8-aff3-4d7e-a188-54b1cc1fed85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5c2a27e0-4e9b-442d-8a05-3ba276431b0f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_9cdba1a8-aff3-4d7e-a188-54b1cc1fed85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_ec2395aa-6609-4f23-a82e-b843183ab46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_9cdba1a8-aff3-4d7e-a188-54b1cc1fed85" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_ec2395aa-6609-4f23-a82e-b843183ab46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_CARESActMember_c4d6a740-7282-4ab9-ba6e-4ab468a2022b" xlink:href="isee-20211231.xsd#isee_CARESActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_ec2395aa-6609-4f23-a82e-b843183ab46b" xlink:to="loc_isee_CARESActMember_c4d6a740-7282-4ab9-ba6e-4ab468a2022b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_295175be-bed5-425d-a2e3-46f22a9dc830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5c2a27e0-4e9b-442d-8a05-3ba276431b0f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_295175be-bed5-425d-a2e3-46f22a9dc830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_930e6fc2-a50c-461b-91c5-7e970d8e35c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_295175be-bed5-425d-a2e3-46f22a9dc830" xlink:to="loc_us-gaap_OperatingLossCarryforwards_930e6fc2-a50c-461b-91c5-7e970d8e35c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c42f8808-507b-45f8-9af1-eca8633f89d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_295175be-bed5-425d-a2e3-46f22a9dc830" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c42f8808-507b-45f8-9af1-eca8633f89d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_d3aac022-6dc0-4041-a75b-ff00fa36e01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_295175be-bed5-425d-a2e3-46f22a9dc830" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_d3aac022-6dc0-4041-a75b-ff00fa36e01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_875f43d0-00da-4d0b-a7c5-3779eff1070f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_295175be-bed5-425d-a2e3-46f22a9dc830" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_875f43d0-00da-4d0b-a7c5-3779eff1070f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/IncomeTaxesScheduleofPositionwithRespecttoUncertainTaxPositionsDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#IncomeTaxesScheduleofPositionwithRespecttoUncertainTaxPositionsDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/IncomeTaxesScheduleofPositionwithRespecttoUncertainTaxPositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1b2a9121-27f7-489f-b206-354773a77150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3efe6b56-cd11-42ba-97b0-da137a2380b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b2a9121-27f7-489f-b206-354773a77150" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3efe6b56-cd11-42ba-97b0-da137a2380b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_04a8d8f1-bff2-4b4d-b090-7050953e2b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3efe6b56-cd11-42ba-97b0-da137a2380b4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_04a8d8f1-bff2-4b4d-b090-7050953e2b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_807c7552-fcf9-4833-9535-3a86f21644cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3efe6b56-cd11-42ba-97b0-da137a2380b4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_807c7552-fcf9-4833-9535-3a86f21644cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_633c5843-562b-486c-9407-ee06efee630e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3efe6b56-cd11-42ba-97b0-da137a2380b4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_633c5843-562b-486c-9407-ee06efee630e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UnrecognizedTaxBenefitsOtherIncreaseDecrease_2f808ee7-2d19-44ce-972c-9067eca502d1" xlink:href="isee-20211231.xsd#isee_UnrecognizedTaxBenefitsOtherIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3efe6b56-cd11-42ba-97b0-da137a2380b4" xlink:to="loc_isee_UnrecognizedTaxBenefitsOtherIncreaseDecrease_2f808ee7-2d19-44ce-972c-9067eca502d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_02058b3b-b520-4c2e-9433-7be97fa6189b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3efe6b56-cd11-42ba-97b0-da137a2380b4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_02058b3b-b520-4c2e-9433-7be97fa6189b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_cd10db6c-7508-4065-a144-65bc02d52ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3efe6b56-cd11-42ba-97b0-da137a2380b4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_cd10db6c-7508-4065-a144-65bc02d52ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d6925a8c-ce17-4dd7-9bd7-87ef100aff37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3efe6b56-cd11-42ba-97b0-da137a2380b4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d6925a8c-ce17-4dd7-9bd7-87ef100aff37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeases" xlink:type="simple" xlink:href="isee-20211231.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0fd2d8d2-7336-421d-8038-442c1d4fd072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_b2911892-ceca-472a-90d6-2b260ad4b9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0fd2d8d2-7336-421d-8038-442c1d4fd072" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_b2911892-ceca-472a-90d6-2b260ad4b9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="isee-20211231.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6862f7f4-db08-4d34-a5a3-24315a9bd237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_810ee6bf-8a44-4032-ae41-0d70a8ed0afd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6862f7f4-db08-4d34-a5a3-24315a9bd237" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_810ee6bf-8a44-4032-ae41-0d70a8ed0afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#OperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_71adf9ab-902e-4562-92dc-243eca023707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_12e4dff3-c3db-4099-9a26-132e9dc7c6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71adf9ab-902e-4562-92dc-243eca023707" xlink:to="loc_us-gaap_OperatingLeaseExpense_12e4dff3-c3db-4099-9a26-132e9dc7c6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_fed8c03f-7032-4630-a329-06423ec77322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71adf9ab-902e-4562-92dc-243eca023707" xlink:to="loc_us-gaap_OperatingLeasePayments_fed8c03f-7032-4630-a329-06423ec77322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_bf666e41-fcb9-439c-a637-663bc6f75f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71adf9ab-902e-4562-92dc-243eca023707" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_bf666e41-fcb9-439c-a637-663bc6f75f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c317c9ca-00f6-4df3-b88f-9b768197590c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71adf9ab-902e-4562-92dc-243eca023707" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c317c9ca-00f6-4df3-b88f-9b768197590c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturitiesDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#OperatingLeasesScheduleofOperatingLeaseLiabilityMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dcb0f2fe-564f-420b-a6fe-576604dd6c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dcb0f2fe-564f-420b-a6fe-576604dd6c8d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_db55ee04-0ddf-4553-8413-6121ada14f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_db55ee04-0ddf-4553-8413-6121ada14f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ca5b1b46-4d29-48a4-8e57-22eb89a3df2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ca5b1b46-4d29-48a4-8e57-22eb89a3df2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ac50e812-5148-4730-a24c-63ff2cd97b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ac50e812-5148-4730-a24c-63ff2cd97b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6e86421a-cd60-441a-a31a-020f38760f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6e86421a-cd60-441a-a31a-020f38760f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5603b1ae-8c57-4d8e-afc6-e83295f929d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5603b1ae-8c57-4d8e-afc6-e83295f929d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_22e2fbc2-8ba8-4bed-8c28-b24c87a83b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:to="loc_us-gaap_OperatingLeaseLiability_22e2fbc2-8ba8-4bed-8c28-b24c87a83b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a3c6c510-5ce3-42d7-b755-16534fc2df68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a3c6c510-5ce3-42d7-b755-16534fc2df68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c630c184-2203-4c6e-ac0f-3df3e19bc4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_17c47e5d-9cb2-4ffd-9839-5aac4c480848" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c630c184-2203-4c6e-ac0f-3df3e19bc4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturitiesDetails_1" xlink:type="simple" xlink:href="isee-20211231.xsd#OperatingLeasesScheduleofOperatingLeaseLiabilityMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/OperatingLeasesScheduleofOperatingLeaseLiabilityMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="isee-20211231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b2e4617-edd3-489d-a71f-b7f56734d28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_353ae501-a4ed-439d-a10d-c31e26580679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b2e4617-edd3-489d-a71f-b7f56734d28f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_353ae501-a4ed-439d-a10d-c31e26580679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommitmentsandContingenciesZimuraArchemixCorpDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#CommitmentsandContingenciesZimuraArchemixCorpDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommitmentsandContingenciesZimuraArchemixCorpDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f202a75-a729-4bdd-ae16-d6bc84363157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_61d01a52-8917-4a7a-a8df-60ee4a79408a" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f202a75-a729-4bdd-ae16-d6bc84363157" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_61d01a52-8917-4a7a-a8df-60ee4a79408a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_21d9d31c-32d5-4e10-99b0-ad40c9c99882" xlink:href="isee-20211231.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_61d01a52-8917-4a7a-a8df-60ee4a79408a" xlink:to="loc_isee_MilestoneEventsAxis_21d9d31c-32d5-4e10-99b0-ad40c9c99882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_b846f2e7-50c3-4a1e-8e1f-4f20992aac31" xlink:href="isee-20211231.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_21d9d31c-32d5-4e10-99b0-ad40c9c99882" xlink:to="loc_isee_MilestoneEventsDomain_b846f2e7-50c3-4a1e-8e1f-4f20992aac31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_6cdab15a-058e-44ad-a5e9-6435b098007d" xlink:href="isee-20211231.xsd#isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_b846f2e7-50c3-4a1e-8e1f-4f20992aac31" xlink:to="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_6cdab15a-058e-44ad-a5e9-6435b098007d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_FirstIndicationMember_811f31de-a04b-4b9f-b9b4-10d7acf87b7f" xlink:href="isee-20211231.xsd#isee_FirstIndicationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_b846f2e7-50c3-4a1e-8e1f-4f20992aac31" xlink:to="loc_isee_FirstIndicationMember_811f31de-a04b-4b9f-b9b4-10d7acf87b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SecondandThirdIndicationMember_4faee987-e915-46a7-9e24-080f75c478aa" xlink:href="isee-20211231.xsd#isee_SecondandThirdIndicationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_b846f2e7-50c3-4a1e-8e1f-4f20992aac31" xlink:to="loc_isee_SecondandThirdIndicationMember_4faee987-e915-46a7-9e24-080f75c478aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SustainedDeliveryApplicationsMember_f131bc26-a811-459d-8f71-f7df7457f9d3" xlink:href="isee-20211231.xsd#isee_SustainedDeliveryApplicationsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_b846f2e7-50c3-4a1e-8e1f-4f20992aac31" xlink:to="loc_isee_SustainedDeliveryApplicationsMember_f131bc26-a811-459d-8f71-f7df7457f9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedCommercialMilestonesMember_0aef9fb8-3c3a-4bc3-b8e4-9e081d383007" xlink:href="isee-20211231.xsd#isee_AchievementOfSpecifiedCommercialMilestonesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_b846f2e7-50c3-4a1e-8e1f-4f20992aac31" xlink:to="loc_isee_AchievementOfSpecifiedCommercialMilestonesMember_0aef9fb8-3c3a-4bc3-b8e4-9e081d383007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8eab25e2-f282-4b7c-8acf-4893071f2ce4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_61d01a52-8917-4a7a-a8df-60ee4a79408a" xlink:to="loc_srt_CounterpartyNameAxis_8eab25e2-f282-4b7c-8acf-4893071f2ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64941116-6e4c-431c-b675-a84cf66c5255" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_8eab25e2-f282-4b7c-8acf-4893071f2ce4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64941116-6e4c-431c-b675-a84cf66c5255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ArchemixCorpMember_e11f13db-6f85-49fc-b5aa-472ae1b1aceb" xlink:href="isee-20211231.xsd#isee_ArchemixCorpMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64941116-6e4c-431c-b675-a84cf66c5255" xlink:to="loc_isee_ArchemixCorpMember_e11f13db-6f85-49fc-b5aa-472ae1b1aceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9924128b-3f8b-4e58-ad38-aa99598d0919" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_61d01a52-8917-4a7a-a8df-60ee4a79408a" xlink:to="loc_srt_ProductOrServiceAxis_9924128b-3f8b-4e58-ad38-aa99598d0919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bd3e48a0-80bc-431a-94a6-5d291dcc90b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9924128b-3f8b-4e58-ad38-aa99598d0919" xlink:to="loc_srt_ProductsAndServicesDomain_bd3e48a0-80bc-431a-94a6-5d291dcc90b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_C5LicensedProductsMember_537afbd7-515c-487a-9e0b-56523be7a8ae" xlink:href="isee-20211231.xsd#isee_C5LicensedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bd3e48a0-80bc-431a-94a6-5d291dcc90b6" xlink:to="loc_isee_C5LicensedProductsMember_537afbd7-515c-487a-9e0b-56523be7a8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3f304a5d-38ba-447e-999d-489b7f1b2a6d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_61d01a52-8917-4a7a-a8df-60ee4a79408a" xlink:to="loc_srt_RangeAxis_3f304a5d-38ba-447e-999d-489b7f1b2a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ccbeaff5-e732-429f-8699-d964430d5a53" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3f304a5d-38ba-447e-999d-489b7f1b2a6d" xlink:to="loc_srt_RangeMember_ccbeaff5-e732-429f-8699-d964430d5a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8136ea2b-555c-450e-a8da-39f659adfba7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ccbeaff5-e732-429f-8699-d964430d5a53" xlink:to="loc_srt_MaximumMember_8136ea2b-555c-450e-a8da-39f659adfba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e4123fda-3961-471d-93a4-3c4e377247c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_61d01a52-8917-4a7a-a8df-60ee4a79408a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e4123fda-3961-471d-93a4-3c4e377247c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9931c9b3-0053-4d80-9d9e-3a9428f17da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e4123fda-3961-471d-93a4-3c4e377247c7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9931c9b3-0053-4d80-9d9e-3a9428f17da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_3b22326b-5be2-4e57-9e06-0602104066ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9931c9b3-0053-4d80-9d9e-3a9428f17da3" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_3b22326b-5be2-4e57-9e06-0602104066ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_abc107be-e497-404d-8206-80809bf91048" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_61d01a52-8917-4a7a-a8df-60ee4a79408a" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_abc107be-e497-404d-8206-80809bf91048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AmountToBePaidOnAchievementOfMilestone_4f7ead8f-c1e2-41b8-8653-a671f38c7d1f" xlink:href="isee-20211231.xsd#isee_AmountToBePaidOnAchievementOfMilestone"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_abc107be-e497-404d-8206-80809bf91048" xlink:to="loc_isee_AmountToBePaidOnAchievementOfMilestone_4f7ead8f-c1e2-41b8-8653-a671f38c7d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommitmentsandContingenciesIC100UniversityofFloridaResearchFoundationandtheUniversityofPennsylvaniaDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#CommitmentsandContingenciesIC100UniversityofFloridaResearchFoundationandtheUniversityofPennsylvaniaDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommitmentsandContingenciesIC100UniversityofFloridaResearchFoundationandtheUniversityofPennsylvaniaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e7aa34bd-fd4a-4e3a-b67f-9e249cfef792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_56743107-f22e-48e1-aed0-c26cff4732c6" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e7aa34bd-fd4a-4e3a-b67f-9e249cfef792" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_56743107-f22e-48e1-aed0-c26cff4732c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_23d985df-4d0b-49b3-8c28-428921dce527" xlink:href="isee-20211231.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_56743107-f22e-48e1-aed0-c26cff4732c6" xlink:to="loc_isee_MilestoneEventsAxis_23d985df-4d0b-49b3-8c28-428921dce527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_56f4bda5-bd0c-4c15-815a-be87b7d3a8ad" xlink:href="isee-20211231.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_23d985df-4d0b-49b3-8c28-428921dce527" xlink:to="loc_isee_MilestoneEventsDomain_56f4bda5-bd0c-4c15-815a-be87b7d3a8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_b747e81a-ccdf-49a7-b144-dd7e5dd8ea05" xlink:href="isee-20211231.xsd#isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_56f4bda5-bd0c-4c15-815a-be87b7d3a8ad" xlink:to="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_b747e81a-ccdf-49a7-b144-dd7e5dd8ea05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_803a5c3a-d531-47a4-82ba-26c1243b2c01" xlink:href="isee-20211231.xsd#isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_56f4bda5-bd0c-4c15-815a-be87b7d3a8ad" xlink:to="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_803a5c3a-d531-47a4-82ba-26c1243b2c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a37642a9-e05d-4e7e-9b23-f477a79151c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_56743107-f22e-48e1-aed0-c26cff4732c6" xlink:to="loc_srt_CounterpartyNameAxis_a37642a9-e05d-4e7e-9b23-f477a79151c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5661914-2118-44c9-99ed-8886da251faf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a37642a9-e05d-4e7e-9b23-f477a79151c5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5661914-2118-44c9-99ed-8886da251faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityofFloridaResearchFoundationUFRFMember_6d3466f0-0eac-4139-96c1-017a3804ce60" xlink:href="isee-20211231.xsd#isee_UniversityofFloridaResearchFoundationUFRFMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5661914-2118-44c9-99ed-8886da251faf" xlink:to="loc_isee_UniversityofFloridaResearchFoundationUFRFMember_6d3466f0-0eac-4139-96c1-017a3804ce60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e536f6af-a718-41cd-981c-2a062352ad7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_56743107-f22e-48e1-aed0-c26cff4732c6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e536f6af-a718-41cd-981c-2a062352ad7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ec0cb286-8970-478c-9b75-931c1e72bff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e536f6af-a718-41cd-981c-2a062352ad7b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ec0cb286-8970-478c-9b75-931c1e72bff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_RHOadRPLicenseAgreementMember_83037cbf-0914-4eb5-975e-5c8c7fa363d0" xlink:href="isee-20211231.xsd#isee_RHOadRPLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ec0cb286-8970-478c-9b75-931c1e72bff2" xlink:to="loc_isee_RHOadRPLicenseAgreementMember_83037cbf-0914-4eb5-975e-5c8c7fa363d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_b71cab5d-e25a-4472-ad65-cf87b043f55b" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_56743107-f22e-48e1-aed0-c26cff4732c6" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_b71cab5d-e25a-4472-ad65-cf87b043f55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AmountToBePaidOnAchievementOfMilestone_bb200e07-3350-4386-8235-f1a7d509c716" xlink:href="isee-20211231.xsd#isee_AmountToBePaidOnAchievementOfMilestone"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_b71cab5d-e25a-4472-ad65-cf87b043f55b" xlink:to="loc_isee_AmountToBePaidOnAchievementOfMilestone_bb200e07-3350-4386-8235-f1a7d509c716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommitmentsandContingenciesIC200UniversityofPennsylvaniaandtheUniversityofFloridaResearchFoundationDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#CommitmentsandContingenciesIC200UniversityofPennsylvaniaandtheUniversityofFloridaResearchFoundationDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommitmentsandContingenciesIC200UniversityofPennsylvaniaandtheUniversityofFloridaResearchFoundationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cc5121f-d202-448a-a80a-d71b01d27835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_ffb0f3ce-a550-4939-83dd-49e309198f76" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cc5121f-d202-448a-a80a-d71b01d27835" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_ffb0f3ce-a550-4939-83dd-49e309198f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_63358df1-4025-4cbd-978f-384cc5c20ec1" xlink:href="isee-20211231.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_ffb0f3ce-a550-4939-83dd-49e309198f76" xlink:to="loc_isee_MilestoneEventsAxis_63358df1-4025-4cbd-978f-384cc5c20ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_ad3aeda9-9fa1-41a4-99c0-44f403628811" xlink:href="isee-20211231.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_63358df1-4025-4cbd-978f-384cc5c20ec1" xlink:to="loc_isee_MilestoneEventsDomain_ad3aeda9-9fa1-41a4-99c0-44f403628811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_ee018f12-1cf1-414d-8497-0a97a7845bce" xlink:href="isee-20211231.xsd#isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_ad3aeda9-9fa1-41a4-99c0-44f403628811" xlink:to="loc_isee_SpecifiedClinicalMarketingApprovalandReimbursementApprovalMilestonesRelatedtoaLicensedProductMember_ee018f12-1cf1-414d-8497-0a97a7845bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_002104c6-3704-4659-9a8b-f5e9b19f7d61" xlink:href="isee-20211231.xsd#isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_ad3aeda9-9fa1-41a4-99c0-44f403628811" xlink:to="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_002104c6-3704-4659-9a8b-f5e9b19f7d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_341c3e4b-c6b6-44bb-a70a-81697de449d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_ffb0f3ce-a550-4939-83dd-49e309198f76" xlink:to="loc_srt_CounterpartyNameAxis_341c3e4b-c6b6-44bb-a70a-81697de449d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ae2450ee-9d87-4801-9776-d5eb16df7422" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_341c3e4b-c6b6-44bb-a70a-81697de449d9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ae2450ee-9d87-4801-9776-d5eb16df7422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityOfFloridaResearchFoundationUFRFAndUniversityOfPennsylvaniaPennMember_1ae75870-7038-4349-99fe-865717fec942" xlink:href="isee-20211231.xsd#isee_UniversityOfFloridaResearchFoundationUFRFAndUniversityOfPennsylvaniaPennMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ae2450ee-9d87-4801-9776-d5eb16df7422" xlink:to="loc_isee_UniversityOfFloridaResearchFoundationUFRFAndUniversityOfPennsylvaniaPennMember_1ae75870-7038-4349-99fe-865717fec942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_efb58240-a1dc-4e68-9dce-5c382ef3fda2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_ffb0f3ce-a550-4939-83dd-49e309198f76" xlink:to="loc_srt_ProductOrServiceAxis_efb58240-a1dc-4e68-9dce-5c382ef3fda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f618f5e8-f392-42a7-ac17-6a5f4cbae847" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_efb58240-a1dc-4e68-9dce-5c382ef3fda2" xlink:to="loc_srt_ProductsAndServicesDomain_f618f5e8-f392-42a7-ac17-6a5f4cbae847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PrimaryLicensedProductMember_56a4c458-434a-46f5-9340-6cdf178a75a5" xlink:href="isee-20211231.xsd#isee_PrimaryLicensedProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f618f5e8-f392-42a7-ac17-6a5f4cbae847" xlink:to="loc_isee_PrimaryLicensedProductMember_56a4c458-434a-46f5-9340-6cdf178a75a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_OtherLicensedProductMember_3194777e-b345-49a4-8a5f-89f19af16dd5" xlink:href="isee-20211231.xsd#isee_OtherLicensedProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f618f5e8-f392-42a7-ac17-6a5f4cbae847" xlink:to="loc_isee_OtherLicensedProductMember_3194777e-b345-49a4-8a5f-89f19af16dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1498c5e8-b914-4db1-ad13-3673e79f83e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_ffb0f3ce-a550-4939-83dd-49e309198f76" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1498c5e8-b914-4db1-ad13-3673e79f83e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2d07295e-4d97-44bc-a9ff-abd6c9b3cbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1498c5e8-b914-4db1-ad13-3673e79f83e7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2d07295e-4d97-44bc-a9ff-abd6c9b3cbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ef896cf5-3109-4fed-934c-452dfbeaf605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2d07295e-4d97-44bc-a9ff-abd6c9b3cbfa" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ef896cf5-3109-4fed-934c-452dfbeaf605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_1d2f1ddc-2b50-4294-9b55-ca88eb721cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_ffb0f3ce-a550-4939-83dd-49e309198f76" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_1d2f1ddc-2b50-4294-9b55-ca88eb721cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_09aeec61-21f2-4b18-88a7-1eba7633c711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_1d2f1ddc-2b50-4294-9b55-ca88eb721cf3" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_09aeec61-21f2-4b18-88a7-1eba7633c711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_BEST1LicenseAgreementMember_11587502-e1c1-4608-bb60-528d38a1be54" xlink:href="isee-20211231.xsd#isee_BEST1LicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_09aeec61-21f2-4b18-88a7-1eba7633c711" xlink:to="loc_isee_BEST1LicenseAgreementMember_11587502-e1c1-4608-bb60-528d38a1be54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_15fb8ea4-ecb1-4c07-93eb-c4912e287a2d" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_ffb0f3ce-a550-4939-83dd-49e309198f76" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_15fb8ea4-ecb1-4c07-93eb-c4912e287a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PaymentsForLicenseFees_5e2973a4-fc46-4d2c-8584-ddab061723aa" xlink:href="isee-20211231.xsd#isee_PaymentsForLicenseFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_15fb8ea4-ecb1-4c07-93eb-c4912e287a2d" xlink:to="loc_isee_PaymentsForLicenseFees_5e2973a4-fc46-4d2c-8584-ddab061723aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_NumberOfLicensedProducts_f39e0af3-2121-450c-b495-082be1de3148" xlink:href="isee-20211231.xsd#isee_NumberOfLicensedProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_15fb8ea4-ecb1-4c07-93eb-c4912e287a2d" xlink:to="loc_isee_NumberOfLicensedProducts_f39e0af3-2121-450c-b495-082be1de3148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommitmentsandContingenciesminiCEP290ProgramUniversityofMassachusettsDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#CommitmentsandContingenciesminiCEP290ProgramUniversityofMassachusettsDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommitmentsandContingenciesminiCEP290ProgramUniversityofMassachusettsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_058f19d8-b8cb-4cc2-a839-cc44fc7c66d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_95c628c8-e858-4c8f-bb63-d17b43e9c344" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_058f19d8-b8cb-4cc2-a839-cc44fc7c66d5" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_95c628c8-e858-4c8f-bb63-d17b43e9c344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsAxis_6a593117-0125-4eee-b6ad-1e135363a8e0" xlink:href="isee-20211231.xsd#isee_MilestoneEventsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_95c628c8-e858-4c8f-bb63-d17b43e9c344" xlink:to="loc_isee_MilestoneEventsAxis_6a593117-0125-4eee-b6ad-1e135363a8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MilestoneEventsDomain_12352806-b3e3-407d-adb4-c8c90777ef51" xlink:href="isee-20211231.xsd#isee_MilestoneEventsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsAxis_6a593117-0125-4eee-b6ad-1e135363a8e0" xlink:to="loc_isee_MilestoneEventsDomain_12352806-b3e3-407d-adb4-c8c90777ef51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_3cd8387e-6aab-4b17-bcac-37eb471f1ce6" xlink:href="isee-20211231.xsd#isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_12352806-b3e3-407d-adb4-c8c90777ef51" xlink:to="loc_isee_AchievementOfSpecifiedClinicalAndRegulatoryMilestonesMember_3cd8387e-6aab-4b17-bcac-37eb471f1ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_76f457de-8705-462c-9749-ab31121a4f38" xlink:href="isee-20211231.xsd#isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_MilestoneEventsDomain_12352806-b3e3-407d-adb4-c8c90777ef51" xlink:to="loc_isee_SpecifiedCommercialSalesMilestonesRelatedtoaLicensedProductMember_76f457de-8705-462c-9749-ab31121a4f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9e2925be-9506-446b-b297-759fdb301eac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_95c628c8-e858-4c8f-bb63-d17b43e9c344" xlink:to="loc_srt_CounterpartyNameAxis_9e2925be-9506-446b-b297-759fdb301eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95994ae5-9571-42f9-9c65-137adcbca69c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9e2925be-9506-446b-b297-759fdb301eac" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95994ae5-9571-42f9-9c65-137adcbca69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_UniversityOfMassachusettsUMassMember_b56900d1-2a8f-4d77-8e6d-0c648472923f" xlink:href="isee-20211231.xsd#isee_UniversityOfMassachusettsUMassMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95994ae5-9571-42f9-9c65-137adcbca69c" xlink:to="loc_isee_UniversityOfMassachusettsUMassMember_b56900d1-2a8f-4d77-8e6d-0c648472923f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_391feef9-d689-470e-a05c-1f9668e56c10" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_95c628c8-e858-4c8f-bb63-d17b43e9c344" xlink:to="loc_srt_ProductOrServiceAxis_391feef9-d689-470e-a05c-1f9668e56c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_952c8544-eff2-460f-b804-2d95119066e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_391feef9-d689-470e-a05c-1f9668e56c10" xlink:to="loc_srt_ProductsAndServicesDomain_952c8544-eff2-460f-b804-2d95119066e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_MiniCEP290Member_17b7a8ec-a3cc-46f4-8893-37153b31bddf" xlink:href="isee-20211231.xsd#isee_MiniCEP290Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_952c8544-eff2-460f-b804-2d95119066e8" xlink:to="loc_isee_MiniCEP290Member_17b7a8ec-a3cc-46f4-8893-37153b31bddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_08373050-f49b-4f29-a8f4-c25ab721b877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_95c628c8-e858-4c8f-bb63-d17b43e9c344" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_08373050-f49b-4f29-a8f4-c25ab721b877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7b67bbdd-9708-4ad1-93cd-12fa6a118564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_08373050-f49b-4f29-a8f4-c25ab721b877" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7b67bbdd-9708-4ad1-93cd-12fa6a118564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3aff2357-46d2-4662-91f5-369b020ded66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b67bbdd-9708-4ad1-93cd-12fa6a118564" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3aff2357-46d2-4662-91f5-369b020ded66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_533af04f-5a7f-4ca8-b118-24cc030b99b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_95c628c8-e858-4c8f-bb63-d17b43e9c344" xlink:to="loc_us-gaap_TypeOfArrangementAxis_533af04f-5a7f-4ca8-b118-24cc030b99b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e45f22a0-2189-4735-af1c-82d225b2d4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_533af04f-5a7f-4ca8-b118-24cc030b99b1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e45f22a0-2189-4735-af1c-82d225b2d4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_89fceca8-3fa6-4247-93cf-bb5db896883e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e45f22a0-2189-4735-af1c-82d225b2d4db" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_89fceca8-3fa6-4247-93cf-bb5db896883e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_372d0bfe-896d-4ced-8e1a-9a242c8805dd" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_95c628c8-e858-4c8f-bb63-d17b43e9c344" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_372d0bfe-896d-4ced-8e1a-9a242c8805dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_PaymentsForLicenseFees_4d680084-2230-4b9a-811d-3fed05ae3a3f" xlink:href="isee-20211231.xsd#isee_PaymentsForLicenseFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_372d0bfe-896d-4ced-8e1a-9a242c8805dd" xlink:to="loc_isee_PaymentsForLicenseFees_4d680084-2230-4b9a-811d-3fed05ae3a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_SharesIssuedForLicenseFees_64039082-8262-4c5f-a1b8-e5f75206cf49" xlink:href="isee-20211231.xsd#isee_SharesIssuedForLicenseFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_372d0bfe-896d-4ced-8e1a-9a242c8805dd" xlink:to="loc_isee_SharesIssuedForLicenseFees_64039082-8262-4c5f-a1b8-e5f75206cf49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommitmentsandContingenciesIC_500FormerEquityholdersofInception4Details" xlink:type="simple" xlink:href="isee-20211231.xsd#CommitmentsandContingenciesIC_500FormerEquityholdersofInception4Details"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommitmentsandContingenciesIC_500FormerEquityholdersofInception4Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_af934522-8b76-49ac-b2a5-7ac0467063aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_4936e73d-c369-470f-bcc3-12d92a26340f" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_af934522-8b76-49ac-b2a5-7ac0467063aa" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_4936e73d-c369-470f-bcc3-12d92a26340f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_f5ab3117-d04e-4230-afb9-c447159edf5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_4936e73d-c369-470f-bcc3-12d92a26340f" xlink:to="loc_us-gaap_AssetAcquisitionAxis_f5ab3117-d04e-4230-afb9-c447159edf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_05192368-0209-441c-8845-8b63d0971c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_f5ab3117-d04e-4230-afb9-c447159edf5c" xlink:to="loc_us-gaap_AssetAcquisitionDomain_05192368-0209-441c-8845-8b63d0971c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_Inception4Member_cb426837-8e4c-44cb-8872-4e42624fa4d7" xlink:href="isee-20211231.xsd#isee_Inception4Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_05192368-0209-441c-8845-8b63d0971c5b" xlink:to="loc_isee_Inception4Member_cb426837-8e4c-44cb-8872-4e42624fa4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6decd3a1-1fdf-445e-8cde-862b5ce91c40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_4936e73d-c369-470f-bcc3-12d92a26340f" xlink:to="loc_srt_ProductOrServiceAxis_6decd3a1-1fdf-445e-8cde-862b5ce91c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2d1de207-d0f2-43f6-b213-2a4ff2b04e58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6decd3a1-1fdf-445e-8cde-862b5ce91c40" xlink:to="loc_srt_ProductsAndServicesDomain_2d1de207-d0f2-43f6-b213-2a4ff2b04e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_GAProductMember_6c21b2d6-e0b5-4ccf-9548-3e2ee5a19e2f" xlink:href="isee-20211231.xsd#isee_GAProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2d1de207-d0f2-43f6-b213-2a4ff2b04e58" xlink:to="loc_isee_GAProductMember_6c21b2d6-e0b5-4ccf-9548-3e2ee5a19e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_WetAMDProductMember_d258968c-e2c1-46a6-9985-1c20c5e14936" xlink:href="isee-20211231.xsd#isee_WetAMDProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2d1de207-d0f2-43f6-b213-2a4ff2b04e58" xlink:to="loc_isee_WetAMDProductMember_d258968c-e2c1-46a6-9985-1c20c5e14936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_838868a5-5e00-467b-9273-6f6f127169bf" xlink:href="isee-20211231.xsd#isee_ScheduleOfCommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesTable_4936e73d-c369-470f-bcc3-12d92a26340f" xlink:to="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_838868a5-5e00-467b-9273-6f6f127169bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesValueHigh_10d94346-a9fa-4749-bdaf-18f67b4a3c18" xlink:href="isee-20211231.xsd#isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_838868a5-5e00-467b-9273-6f6f127169bf" xlink:to="loc_isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesValueHigh_10d94346-a9fa-4749-bdaf-18f67b4a3c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionClinicalAndMarketingApprovalMilestones_fad5052a-be38-449d-8c74-75325c872709" xlink:href="isee-20211231.xsd#isee_AssetAcquisitionClinicalAndMarketingApprovalMilestones"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_838868a5-5e00-467b-9273-6f6f127169bf" xlink:to="loc_isee_AssetAcquisitionClinicalAndMarketingApprovalMilestones_fad5052a-be38-449d-8c74-75325c872709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionMilestonePaymentSharePriceBasisForCalculationTradingDays_37948cc6-1ea8-4bef-b6b3-6e465365f96f" xlink:href="isee-20211231.xsd#isee_AssetAcquisitionMilestonePaymentSharePriceBasisForCalculationTradingDays"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_838868a5-5e00-467b-9273-6f6f127169bf" xlink:to="loc_isee_AssetAcquisitionMilestonePaymentSharePriceBasisForCalculationTradingDays_37948cc6-1ea8-4bef-b6b3-6e465365f96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesSharesIssuableHigh_3ee4f17d-86db-4580-becb-e591f2f09184" xlink:href="isee-20211231.xsd#isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesSharesIssuableHigh"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_838868a5-5e00-467b-9273-6f6f127169bf" xlink:to="loc_isee_AssetAcquisitionContingentConsiderationArrangementsRangeOfOutcomesSharesIssuableHigh_3ee4f17d-86db-4580-becb-e591f2f09184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_AssetAcquisitionContingentConsiderationArrangementsContingentlyIssuableSharesAsAPercentageOfSharesOutstanding_e41686e9-0a4a-4199-8fa2-9515869b4ee0" xlink:href="isee-20211231.xsd#isee_AssetAcquisitionContingentConsiderationArrangementsContingentlyIssuableSharesAsAPercentageOfSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ScheduleOfCommitmentsAndContingenciesLineItems_838868a5-5e00-467b-9273-6f6f127169bf" xlink:to="loc_isee_AssetAcquisitionContingentConsiderationArrangementsContingentlyIssuableSharesAsAPercentageOfSharesOutstanding_e41686e9-0a4a-4199-8fa2-9515869b4ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/CommitmentsandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#CommitmentsandContingenciesLegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/CommitmentsandContingenciesLegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_869bc4af-7c08-4c5c-ad17-026853dae9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_210c0d25-2a6e-48a3-8c32-e9e4242203b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_869bc4af-7c08-4c5c-ad17-026853dae9c8" xlink:to="loc_us-gaap_LossContingenciesTable_210c0d25-2a6e-48a3-8c32-e9e4242203b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_0423cc3d-ffec-4e16-99f1-0ef3375e2dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_210c0d25-2a6e-48a3-8c32-e9e4242203b0" xlink:to="loc_us-gaap_LitigationStatusAxis_0423cc3d-ffec-4e16-99f1-0ef3375e2dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1febf76b-6703-47ee-9979-65904bc7e2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_0423cc3d-ffec-4e16-99f1-0ef3375e2dc7" xlink:to="loc_us-gaap_LitigationStatusDomain_1febf76b-6703-47ee-9979-65904bc7e2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_14246856-e1ad-4e33-8939-c6cba3f5ef81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_1febf76b-6703-47ee-9979-65904bc7e2f3" xlink:to="loc_us-gaap_SettledLitigationMember_14246856-e1ad-4e33-8939-c6cba3f5ef81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_100200ae-7ffe-4218-baee-1a6892b6437a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_210c0d25-2a6e-48a3-8c32-e9e4242203b0" xlink:to="loc_us-gaap_LossContingenciesLineItems_100200ae-7ffe-4218-baee-1a6892b6437a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_LitigationStayPeriod_486b8f40-733f-4ac6-88c2-dee84a99d396" xlink:href="isee-20211231.xsd#isee_LitigationStayPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_100200ae-7ffe-4218-baee-1a6892b6437a" xlink:to="loc_isee_LitigationStayPeriod_486b8f40-733f-4ac6-88c2-dee84a99d396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_c5cf1991-1dd7-4138-97b0-50c9c040f589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_100200ae-7ffe-4218-baee-1a6892b6437a" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_c5cf1991-1dd7-4138-97b0-50c9c040f589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlans" xlink:type="simple" xlink:href="isee-20211231.xsd#StockBasedCompensationandCompensationPlans"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55d10bef-0454-4247-a24a-3a73aea6d026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_833e66c7-38a3-48d3-b74d-c67e216ab095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_55d10bef-0454-4247-a24a-3a73aea6d026" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_833e66c7-38a3-48d3-b74d-c67e216ab095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansTables" xlink:type="simple" xlink:href="isee-20211231.xsd#StockBasedCompensationandCompensationPlansTables"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4dd28a7f-34fe-43cc-b450-037211267c04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e59ce09d-2eea-4b0e-a335-1a67f379e8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4dd28a7f-34fe-43cc-b450-037211267c04" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e59ce09d-2eea-4b0e-a335-1a67f379e8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_08380d08-998d-40f9-8e2a-bedef17e8aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4dd28a7f-34fe-43cc-b450-037211267c04" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_08380d08-998d-40f9-8e2a-bedef17e8aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_ba559f78-4e07-4ba3-8df4-b22a24faaed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4dd28a7f-34fe-43cc-b450-037211267c04" xlink:to="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_ba559f78-4e07-4ba3-8df4-b22a24faaed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_8a3817c1-99f1-4cdf-97c2-dd9e70ca3d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4dd28a7f-34fe-43cc-b450-037211267c04" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_8a3817c1-99f1-4cdf-97c2-dd9e70ca3d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansNarrativeDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#StockBasedCompensationandCompensationPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b8b0022-75e6-4894-bfc7-859e2089cd17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52cf0b0a-409e-42eb-9507-8d6739c7ccfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b8b0022-75e6-4894-bfc7-859e2089cd17" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52cf0b0a-409e-42eb-9507-8d6739c7ccfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3809ea6c-59b2-491f-b7cd-931a1583de24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52cf0b0a-409e-42eb-9507-8d6739c7ccfb" xlink:to="loc_us-gaap_PlanNameAxis_3809ea6c-59b2-491f-b7cd-931a1583de24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_74aa4cff-b419-41b4-80c3-a00efd435b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3809ea6c-59b2-491f-b7cd-931a1583de24" xlink:to="loc_us-gaap_PlanNameDomain_74aa4cff-b419-41b4-80c3-a00efd435b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_StockIncentive2013PlanMember_63148ebf-d3d4-46a0-a8e9-c78fd4ff949b" xlink:href="isee-20211231.xsd#isee_StockIncentive2013PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_74aa4cff-b419-41b4-80c3-a00efd435b3c" xlink:to="loc_isee_StockIncentive2013PlanMember_63148ebf-d3d4-46a0-a8e9-c78fd4ff949b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_StockIncentive2007PlanMember_f684954f-b34f-4077-9232-67e53b80f349" xlink:href="isee-20211231.xsd#isee_StockIncentive2007PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_74aa4cff-b419-41b4-80c3-a00efd435b3c" xlink:to="loc_isee_StockIncentive2007PlanMember_f684954f-b34f-4077-9232-67e53b80f349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_TwoThousandNineteenInducementPlanMember_d6e7f26f-0160-45a7-b1e6-b28d47245198" xlink:href="isee-20211231.xsd#isee_TwoThousandNineteenInducementPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_74aa4cff-b419-41b4-80c3-a00efd435b3c" xlink:to="loc_isee_TwoThousandNineteenInducementPlanMember_d6e7f26f-0160-45a7-b1e6-b28d47245198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf522ed5-44c4-4230-a794-3999e78803cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52cf0b0a-409e-42eb-9507-8d6739c7ccfb" xlink:to="loc_srt_RangeAxis_cf522ed5-44c4-4230-a794-3999e78803cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9db98f41-ded4-48b7-a123-5a70a10d484a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cf522ed5-44c4-4230-a794-3999e78803cf" xlink:to="loc_srt_RangeMember_9db98f41-ded4-48b7-a123-5a70a10d484a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bd1a04d3-2540-4df1-9fd2-8c59c175b0ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9db98f41-ded4-48b7-a123-5a70a10d484a" xlink:to="loc_srt_MaximumMember_bd1a04d3-2540-4df1-9fd2-8c59c175b0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_e91f6976-09b1-423d-841e-c12cbad6ec3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52cf0b0a-409e-42eb-9507-8d6739c7ccfb" xlink:to="loc_srt_TitleOfIndividualAxis_e91f6976-09b1-423d-841e-c12cbad6ec3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8e8ce89d-addb-4424-9aec-08feca7d2cbc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_e91f6976-09b1-423d-841e-c12cbad6ec3c" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8e8ce89d-addb-4424-9aec-08feca7d2cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_EmployeesMember_754fc616-9ca2-427a-ae0b-b85e74b75631" xlink:href="isee-20211231.xsd#isee_EmployeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8e8ce89d-addb-4424-9aec-08feca7d2cbc" xlink:to="loc_isee_EmployeesMember_754fc616-9ca2-427a-ae0b-b85e74b75631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_79967172-b2bb-4a02-8e5e-9d43ccf186ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52cf0b0a-409e-42eb-9507-8d6739c7ccfb" xlink:to="loc_us-gaap_AwardTypeAxis_79967172-b2bb-4a02-8e5e-9d43ccf186ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c076ae2b-7ee4-4f4b-bdaf-bd073c38d485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_79967172-b2bb-4a02-8e5e-9d43ccf186ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c076ae2b-7ee4-4f4b-bdaf-bd073c38d485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d61de05d-528d-40eb-a188-74b2a3c62ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c076ae2b-7ee4-4f4b-bdaf-bd073c38d485" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d61de05d-528d-40eb-a188-74b2a3c62ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_5356f11a-d757-418c-a73b-cc1bc035e306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c076ae2b-7ee4-4f4b-bdaf-bd073c38d485" xlink:to="loc_us-gaap_EmployeeStockMember_5356f11a-d757-418c-a73b-cc1bc035e306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_26988523-c087-4e16-b15a-f0592599eef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c076ae2b-7ee4-4f4b-bdaf-bd073c38d485" xlink:to="loc_us-gaap_RestrictedStockMember_26988523-c087-4e16-b15a-f0592599eef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5c873f19-530b-4690-bc00-28946dbff622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52cf0b0a-409e-42eb-9507-8d6739c7ccfb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5c873f19-530b-4690-bc00-28946dbff622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_41b9d4a4-05bc-41ad-a294-a7f59255a4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5c873f19-530b-4690-bc00-28946dbff622" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_41b9d4a4-05bc-41ad-a294-a7f59255a4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1c11f382-a6a8-4db6-ab3e-36f10b55175c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_41b9d4a4-05bc-41ad-a294-a7f59255a4c6" xlink:to="loc_us-gaap_SubsequentEventMember_1c11f382-a6a8-4db6-ab3e-36f10b55175c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52cf0b0a-409e-42eb-9507-8d6739c7ccfb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5e7f1aeb-9ae5-4a5b-8873-f7466af61f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5e7f1aeb-9ae5-4a5b-8873-f7466af61f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cf57dcd7-9f9a-457c-9911-4ed20c76627f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cf57dcd7-9f9a-457c-9911-4ed20c76627f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInSharesReservedForIssuance_0a734a48-5ddd-4fd1-b423-d10b7380ec72" xlink:href="isee-20211231.xsd#isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInSharesReservedForIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInSharesReservedForIssuance_0a734a48-5ddd-4fd1-b423-d10b7380ec72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAnnualIncreaseInSharesReservedForIssuance_5cfa0f8d-ba9e-4e7c-9cf4-920378c98b24" xlink:href="isee-20211231.xsd#isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAnnualIncreaseInSharesReservedForIssuance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAnnualIncreaseInSharesReservedForIssuance_5cfa0f8d-ba9e-4e7c-9cf4-920378c98b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_07e530b2-9cc8-4e79-b6ea-3c8a105df8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_07e530b2-9cc8-4e79-b6ea-3c8a105df8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_50acefb4-2a4a-4b4a-8086-130f0b783b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_50acefb4-2a4a-4b4a-8086-130f0b783b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWithholdingPeriod_1381e948-a909-42ef-a7ff-24c7cabb2460" xlink:href="isee-20211231.xsd#isee_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWithholdingPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_isee_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWithholdingPeriod_1381e948-a909-42ef-a7ff-24c7cabb2460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_466cc705-b8ae-4b79-9d9f-52c805271565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_466cc705-b8ae-4b79-9d9f-52c805271565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_58d52a14-92df-4aad-a5a9-6756c25e1aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_58d52a14-92df-4aad-a5a9-6756c25e1aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_5ed05445-32f6-4afa-b168-37ff26161938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_5ed05445-32f6-4afa-b168-37ff26161938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2673c7a3-8c41-4e15-bd4d-0e7d2a9f5594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2673c7a3-8c41-4e15-bd4d-0e7d2a9f5594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_cb7dbde3-129c-4214-b507-32f1da0ea597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_cb7dbde3-129c-4214-b507-32f1da0ea597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_bbed810d-0cf0-41d1-bf09-5719f5e02c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_bbed810d-0cf0-41d1-bf09-5719f5e02c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8db77514-5ff4-495e-b677-8bc9c34ff1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8db77514-5ff4-495e-b677-8bc9c34ff1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_eff28713-5dc7-4ac2-9966-682de126bb85" xlink:href="isee-20211231.xsd#isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_eff28713-5dc7-4ac2-9966-682de126bb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_d816a1f3-95b9-4d26-8d31-ee9a6921114a" xlink:href="isee-20211231.xsd#isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_d816a1f3-95b9-4d26-8d31-ee9a6921114a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest_abfbb949-7b6c-4d0a-b492-323e972ea36d" xlink:href="isee-20211231.xsd#isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_isee_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest_abfbb949-7b6c-4d0a-b492-323e972ea36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f4103b80-ca86-48f5-ac38-ee1146c7b24c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f4103b80-ca86-48f5-ac38-ee1146c7b24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_89474e1c-db29-4e35-b453-569dcae744c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_89474e1c-db29-4e35-b453-569dcae744c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_df54c4c2-3b28-46a9-a946-8030a263e788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_df54c4c2-3b28-46a9-a946-8030a263e788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_ab2cf552-9442-45e5-97ef-48a90ee8fce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c57eb7e2-0524-4378-b66c-d53c4f2f629c" xlink:to="loc_us-gaap_ProceedsFromStockPlans_ab2cf552-9442-45e5-97ef-48a90ee8fce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#StockBasedCompensationandCompensationPlansSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12de8bc6-a929-4a4e-8ba7-cd697dede455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0198d69f-89df-4ecb-9051-e96b51a21d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12de8bc6-a929-4a4e-8ba7-cd697dede455" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0198d69f-89df-4ecb-9051-e96b51a21d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fb1eb8bb-47d1-4a38-be2d-a907d6352f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0198d69f-89df-4ecb-9051-e96b51a21d5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fb1eb8bb-47d1-4a38-be2d-a907d6352f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2d8e0596-0c86-48ec-a547-c395b5f69856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0198d69f-89df-4ecb-9051-e96b51a21d5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2d8e0596-0c86-48ec-a547-c395b5f69856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d41cee6-e137-445c-8600-f1fa89f8e4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0198d69f-89df-4ecb-9051-e96b51a21d5b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d41cee6-e137-445c-8600-f1fa89f8e4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_63d8c559-38dd-495f-b408-792dbb338760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0198d69f-89df-4ecb-9051-e96b51a21d5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_63d8c559-38dd-495f-b408-792dbb338760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9207bf9f-d975-44b4-86f2-e28f1d2dd092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0198d69f-89df-4ecb-9051-e96b51a21d5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9207bf9f-d975-44b4-86f2-e28f1d2dd092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17bb09e6-f30d-4cd6-b47b-2b87812e318b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12de8bc6-a929-4a4e-8ba7-cd697dede455" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17bb09e6-f30d-4cd6-b47b-2b87812e318b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ff739c15-f8ab-440e-8da9-e02f9f5c1efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17bb09e6-f30d-4cd6-b47b-2b87812e318b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ff739c15-f8ab-440e-8da9-e02f9f5c1efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f5dcf1a7-d6bd-4172-aaee-2c8ff316eb93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17bb09e6-f30d-4cd6-b47b-2b87812e318b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f5dcf1a7-d6bd-4172-aaee-2c8ff316eb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cc258209-b313-4f93-981a-9fc19b50c8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17bb09e6-f30d-4cd6-b47b-2b87812e318b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cc258209-b313-4f93-981a-9fc19b50c8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_75d86206-94f2-4e82-85ac-8764aca8f227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17bb09e6-f30d-4cd6-b47b-2b87812e318b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_75d86206-94f2-4e82-85ac-8764aca8f227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_464fdabf-3148-4877-8929-dd49a85fd233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_17bb09e6-f30d-4cd6-b47b-2b87812e318b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_464fdabf-3148-4877-8929-dd49a85fd233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_24bbfcd3-5f32-4aa0-9f1d-c589bf0a327d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12de8bc6-a929-4a4e-8ba7-cd697dede455" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_24bbfcd3-5f32-4aa0-9f1d-c589bf0a327d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_79bc838b-342c-4cfe-a549-866228236839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12de8bc6-a929-4a4e-8ba7-cd697dede455" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_79bc838b-342c-4cfe-a549-866228236839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansOptionsOutstandingandExercisablebyExercisePriceandOptionsExercisedDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#StockBasedCompensationandCompensationPlansOptionsOutstandingandExercisablebyExercisePriceandOptionsExercisedDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansOptionsOutstandingandExercisablebyExercisePriceandOptionsExercisedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a74683af-98ea-4864-b550-31c2cddb60bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_30002bf3-214a-4045-a564-28c56e8fb7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a74683af-98ea-4864-b550-31c2cddb60bb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_30002bf3-214a-4045-a564-28c56e8fb7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5eacb56a-6d52-4b61-b172-9a471c3ebf27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_30002bf3-214a-4045-a564-28c56e8fb7da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5eacb56a-6d52-4b61-b172-9a471c3ebf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_608a2407-5a55-4754-b753-e1c9aedc425b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5eacb56a-6d52-4b61-b172-9a471c3ebf27" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_608a2407-5a55-4754-b753-e1c9aedc425b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ExercisePriceRangeOneMember_019f2705-ad4a-4e80-8f29-9e42cca903c8" xlink:href="isee-20211231.xsd#isee_ExercisePriceRangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_608a2407-5a55-4754-b753-e1c9aedc425b" xlink:to="loc_isee_ExercisePriceRangeOneMember_019f2705-ad4a-4e80-8f29-9e42cca903c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ExercisePriceRangeTwoMember_8149671b-35bc-4748-aafe-91786fa6e56c" xlink:href="isee-20211231.xsd#isee_ExercisePriceRangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_608a2407-5a55-4754-b753-e1c9aedc425b" xlink:to="loc_isee_ExercisePriceRangeTwoMember_8149671b-35bc-4748-aafe-91786fa6e56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ExercisePriceRangeThreeMember_c06a6310-1d5e-4cdb-8879-623a67371530" xlink:href="isee-20211231.xsd#isee_ExercisePriceRangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_608a2407-5a55-4754-b753-e1c9aedc425b" xlink:to="loc_isee_ExercisePriceRangeThreeMember_c06a6310-1d5e-4cdb-8879-623a67371530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ExercisePriceRangeFourMember_81cf9553-40d4-4168-8078-b636d7d7e0e8" xlink:href="isee-20211231.xsd#isee_ExercisePriceRangeFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_608a2407-5a55-4754-b753-e1c9aedc425b" xlink:to="loc_isee_ExercisePriceRangeFourMember_81cf9553-40d4-4168-8078-b636d7d7e0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ExercisePriceRangeFiveMember_8c48339e-c275-4491-a648-8606a584b784" xlink:href="isee-20211231.xsd#isee_ExercisePriceRangeFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_608a2407-5a55-4754-b753-e1c9aedc425b" xlink:to="loc_isee_ExercisePriceRangeFiveMember_8c48339e-c275-4491-a648-8606a584b784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5834e1e6-644a-44ce-bd11-79bf7fec800a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_30002bf3-214a-4045-a564-28c56e8fb7da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5834e1e6-644a-44ce-bd11-79bf7fec800a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_0edd43d7-843e-46dc-87ae-555420dbbc89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5834e1e6-644a-44ce-bd11-79bf7fec800a" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_0edd43d7-843e-46dc-87ae-555420dbbc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_3337cb60-c072-4edd-ada0-1e8fe9178e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5834e1e6-644a-44ce-bd11-79bf7fec800a" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_3337cb60-c072-4edd-ada0-1e8fe9178e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsOutstandingAbstract_e74e493c-d7eb-4021-be82-0e338d7e25d6" xlink:href="isee-20211231.xsd#isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsOutstandingAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5834e1e6-644a-44ce-bd11-79bf7fec800a" xlink:to="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsOutstandingAbstract_e74e493c-d7eb-4021-be82-0e338d7e25d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_b513197e-0f16-4aea-8381-083edbf9a16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsOutstandingAbstract_e74e493c-d7eb-4021-be82-0e338d7e25d6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_b513197e-0f16-4aea-8381-083edbf9a16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_848a7238-1c6e-4575-97ea-bd4ea667d31a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsOutstandingAbstract_e74e493c-d7eb-4021-be82-0e338d7e25d6" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_848a7238-1c6e-4575-97ea-bd4ea667d31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_63429445-1137-4f5a-bded-347a2d368299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsOutstandingAbstract_e74e493c-d7eb-4021-be82-0e338d7e25d6" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_63429445-1137-4f5a-bded-347a2d368299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e880ea5a-b0e1-44da-bbf6-9d9eb3679adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsOutstandingAbstract_e74e493c-d7eb-4021-be82-0e338d7e25d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e880ea5a-b0e1-44da-bbf6-9d9eb3679adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsExercisableAbstract_b04016b9-ccd1-4545-b9bc-dfecab603291" xlink:href="isee-20211231.xsd#isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsExercisableAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5834e1e6-644a-44ce-bd11-79bf7fec800a" xlink:to="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsExercisableAbstract_b04016b9-ccd1-4545-b9bc-dfecab603291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_c1b4bf02-09d1-4be0-82ed-b863e62ada9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsExercisableAbstract_b04016b9-ccd1-4545-b9bc-dfecab603291" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_c1b4bf02-09d1-4be0-82ed-b863e62ada9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_509386d7-0dc3-4144-9a70-63a675a0fe5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsExercisableAbstract_b04016b9-ccd1-4545-b9bc-dfecab603291" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_509386d7-0dc3-4144-9a70-63a675a0fe5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ceb5a397-7162-4e07-ae3e-965afa2040c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isee_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOptionsExercisableAbstract_b04016b9-ccd1-4545-b9bc-dfecab603291" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ceb5a397-7162-4e07-ae3e-965afa2040c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansScheduleofCashProceedsFromandAggregateIntrinsicValueofStockOptionsExercisedDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#StockBasedCompensationandCompensationPlansScheduleofCashProceedsFromandAggregateIntrinsicValueofStockOptionsExercisedDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansScheduleofCashProceedsFromandAggregateIntrinsicValueofStockOptionsExercisedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ee779f15-7706-47e9-be23-d3f4e47b8515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c8e72e05-4ff2-4d86-90b8-722c8d888f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ee779f15-7706-47e9-be23-d3f4e47b8515" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c8e72e05-4ff2-4d86-90b8-722c8d888f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_514f4293-6cfe-4da0-bf79-30af0a85111c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ee779f15-7706-47e9-be23-d3f4e47b8515" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_514f4293-6cfe-4da0-bf79-30af0a85111c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansSummaryofOutstandingRSUAwardsGrantedDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#StockBasedCompensationandCompensationPlansSummaryofOutstandingRSUAwardsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/StockBasedCompensationandCompensationPlansSummaryofOutstandingRSUAwardsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b676c8c1-0d66-44f2-bc47-3f3eb1dba6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_522f362c-fd26-4ace-9679-33e3f939e02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b676c8c1-0d66-44f2-bc47-3f3eb1dba6f5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_522f362c-fd26-4ace-9679-33e3f939e02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_08689d3f-cb17-4f55-9a45-7b86697951af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_522f362c-fd26-4ace-9679-33e3f939e02a" xlink:to="loc_us-gaap_AwardTypeAxis_08689d3f-cb17-4f55-9a45-7b86697951af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3bd68958-2d66-4199-a14a-bbb01032c15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_08689d3f-cb17-4f55-9a45-7b86697951af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3bd68958-2d66-4199-a14a-bbb01032c15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_cce308b8-3908-4dfe-a05d-3e0b009bb3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3bd68958-2d66-4199-a14a-bbb01032c15b" xlink:to="loc_us-gaap_RestrictedStockMember_cce308b8-3908-4dfe-a05d-3e0b009bb3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3deb1f1d-0e64-4af9-a41f-19818db71dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_522f362c-fd26-4ace-9679-33e3f939e02a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3deb1f1d-0e64-4af9-a41f-19818db71dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d290657c-5bbd-473f-91cf-3847294b39d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3deb1f1d-0e64-4af9-a41f-19818db71dd5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d290657c-5bbd-473f-91cf-3847294b39d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eeb08fda-8a62-490d-b43b-9a26a5c3d05b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d290657c-5bbd-473f-91cf-3847294b39d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eeb08fda-8a62-490d-b43b-9a26a5c3d05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2d005f90-93ee-413e-9a72-64731523389f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d290657c-5bbd-473f-91cf-3847294b39d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2d005f90-93ee-413e-9a72-64731523389f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6f508d54-0a18-446a-a30b-0bf770491914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d290657c-5bbd-473f-91cf-3847294b39d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6f508d54-0a18-446a-a30b-0bf770491914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_741056e4-599e-417f-b0a9-5cd7b52bf7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d290657c-5bbd-473f-91cf-3847294b39d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_741056e4-599e-417f-b0a9-5cd7b52bf7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_42ac829a-29d4-43bd-812e-080ffdc5107a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d290657c-5bbd-473f-91cf-3847294b39d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_42ac829a-29d4-43bd-812e-080ffdc5107a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0a78aa8d-677c-4dc8-a292-b45217489adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3deb1f1d-0e64-4af9-a41f-19818db71dd5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0a78aa8d-677c-4dc8-a292-b45217489adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4be2dcdd-df0a-4775-b587-13f5856c166d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0a78aa8d-677c-4dc8-a292-b45217489adf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4be2dcdd-df0a-4775-b587-13f5856c166d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638efdd8-3e31-4e3d-9daf-7d868784e758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0a78aa8d-677c-4dc8-a292-b45217489adf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638efdd8-3e31-4e3d-9daf-7d868784e758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_af36a253-79e6-4139-bae3-edc531f6ec5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0a78aa8d-677c-4dc8-a292-b45217489adf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_af36a253-79e6-4139-bae3-edc531f6ec5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fbda87f5-6809-4be8-909d-4f5813f1f866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0a78aa8d-677c-4dc8-a292-b45217489adf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fbda87f5-6809-4be8-909d-4f5813f1f866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_da216f52-645f-4fac-99fe-9dd6e6690e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0a78aa8d-677c-4dc8-a292-b45217489adf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_da216f52-645f-4fac-99fe-9dd6e6690e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="isee-20211231.xsd#EmployeeBenefitPlan"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/EmployeeBenefitPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3caaff71-e1db-4efb-97b0-3eb962a9041c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f1e377e5-ed5b-4f5a-b0e9-f89e865a465b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3caaff71-e1db-4efb-97b0-3eb962a9041c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f1e377e5-ed5b-4f5a-b0e9-f89e865a465b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ivericbio.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="isee-20211231.xsd#EmployeeBenefitPlanDetails"/>
  <link:presentationLink xlink:role="http://www.ivericbio.com/role/EmployeeBenefitPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_83f8c7e7-ea31-465c-b7b4-b08744a32ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_ff5ae2e4-2960-4a45-bfe8-f30ef8f82b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_83f8c7e7-ea31-465c-b7b4-b08744a32ccd" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_ff5ae2e4-2960-4a45-bfe8-f30ef8f82b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
